ILD, hospital admissions 1, main diag only

ILD_HOSPITAL_MAIN

interstitial lung disease: A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of pulmonary alveoli that extends to the interstitium and beyond leading to diffuse pulmonary fibrosis. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Main diagnosis only: side diagnoses are not checked. Registry filters: Hospital discharge: ICD-10 — J84 Hospital discharge: ICD-9 — 515\|516 Hospital discharge: ICD-8 — 48499\|51701 1 out of 7 registries used, show all original rules.	6569
4. Check minimum number of events None	6569
5. Include endpoints None	6569
6. Filter based on genotype QC (FinnGen only)	5792

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF2
Parent code in ICD-10: J80-J84
Name in latin: Alii morbi interstitiales pulmonum

NAME	ILD_HOSPITAL_MAIN
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY	YES
HD_ICD_10_ATC
HD_ICD_10	J84
HD_ICD_9	515\|516
HD_ICD_8	48499\|51701
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to ILD, hospital admissions 1, main diag only based on the number of shared cases.

Similar with more cases:

Similar with less cases:

ILD medications: nintedanib

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	5792	2384	3408
Unadjusted period prevalence (%)	1.27	0.85	1.56
Median age at first event (years)	70.01	67.68	71.64

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
5955: Matched controls
59550

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

H02AB06

ATC

prednisolone; systemic

5.5

307.7

4558

22281

GD1AA

NOMESCO Finland

Thorax X-ray examination

4.0

307.7

4429

25207

J18.9

ICD-10 Finland

Pneumonia, unspecified

4.0

307.7

3190

13330

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

9.7

307.7

659

752

J96.1

ICD-10 Finland

Chronic respiratory failure

8.3

307.7

510

664

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

4.8

307.7

1419

3625

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

6.3

307.7

932

1716

GDA11

NOMESCO Finland

Thoracoscopic biopsy of lung

79.1

307.7

243

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

7.7

307.7

2259

4403

284

Kela drug reimbursment

Nintedanib and pirfenidone

+∞

307.7

645

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

25.4

307.7

339

141

TGC00

NOMESCO Finland

Bronchial lavation

32.1

307.7

1425

578

R06.0

ICD-10 Finland

Dyspnoea

3.1

307.7

2713

12607

UGC12

NOMESCO Finland

Flexible bronchoscopy

10.7

307.7

2137

2966

L04AX01

ATC

azathioprine; systemic

7.7

307.7

686

984

L01EX09

ATC

nintedanib; oral

+∞

307.7

333

XG410

NOMESCO Finland

Flow-volume spirometry

8.5

307.7

840

1134

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

16.2

307.7

969

706

356

Kela drug reimbursment

Nintedanib and pirfenidone

+∞

307.7

640

L04AX05

ATC

pirfenidone; oral

+∞

307.7

419

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

32.2

307.7

271

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

24.5

307.7

2305

1495

L04AA06

ATC

mycophenolic acid; systemic

14.8

307.7

493

360

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

535.1

307.7

2865

103

GD1AD

NOMESCO Finland

Thorax CT examination

6.8

307.7

1296

2341

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

800.7

307.7

3327

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

813.5

307.7

1812

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

4.5

298.6

808

2006

Z94.2

ICD-10 Finland

Lung transplant status

88.0

277.6

146

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

3.9

273.0

931

2731

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

4.5

272.5

724

1767

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.6

272.4

2911

16127

R03AC02

ATC

salbutamol; inhalant

2.6

272.0

3764

23553

P01BA02

ATC

hydroxychloroquine; oral

3.8

247.1

833

2416

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

3.3

243.7

1083

3756

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

4.3

227.3

631

1586

GX1D5

NOMESCO Finland

Flow volume spirometry

34.9

226.6

143

GX1K5

NOMESCO Finland

Diffusion capacity

16.8

224.5

188

115

J01MA14

ATC

moxifloxacin; systemic

3.3

217.2

948

3237

L01XE31

ATC

[U] nintedanib

+∞

217.0

207

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

4.0

209.8

655

1792

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

18.6

184.5

147

J84.0

ICD-10 Finland

Alveolar and parietoalveolar conditions

884.1

176.0

172

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.3

164.9

1608

8165

J92.0

ICD-10 Finland

Pleural plaque with presence of asbestos

5.3

163.6

344

685

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

4.2

161.7

452

1135

A02BC02

ATC

pantoprazole; systemic

2.3

160.2

4548

34755

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

9.5

155.0

185

200

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

7.5

152.5

223

309

M05BA04

ATC

alendronic acid; oral

2.8

152.1

866

3397

R03BB04

ATC

tiotropium bromide; inhalant

2.6

147.9

1030

4468

R05

ICD-10 Finland

Cough

2.2

147.8

1618

8563

48499

ICD-8 Finland

Acute interstitial pneumonia

704.7

140.4

138

C03CA01

ATC

furosemide; systemic

2.0

138.7

2717

17736

L04AA13

ATC

[U] leflunomide

5.4

135.8

274

525

L04AX03

ATC

methotrexate; systemic

2.8

134.1

760

2963

J61

ICD-10 Finland

Pneumoconiosis due to asbestos and other mineral fibres

9.5

132.7

158

170

GD1BT

NOMESCO Finland

Biopsy of lung with X-ray guidance

447.6

132.6

132

WX721

NOMESCO Finland

Oxygen concentrator therapy

21.4

132.5

GDG10

NOMESCO Finland

Bilateral transplantation of lung

228.4

130.4

134

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

3.1

127.4

573

1964

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

8.8

125.2

159

186

R02

ICPC

Shortness of breath/dyspnoea

2.3

124.7

1159

5687

GX1E5

NOMESCO Finland

Flow volume spirometry and bronchodilation test

10.1

121.9

139

141

XX4BW, ,

NOMESCO Finland

39.4

121.2

127

Kela drug reimbursment

Transplant complication

6.8

120.0

190

287

A07EC01

ATC

sulfasalazine; oral, rectal

2.9

120.0

634

2376

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.1

118.2

1385

7439

J47

ICD-10 Finland

Bronchiectasis

4.9

117.6

263

551

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

4.4

115.7

301

713

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.3

112.4

1027

4983

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

4.1

111.4

319

812

L01BA01

ATC

methotrexate; systemic

3.8

110.6

347

943

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

4.8

108.0

251

543

R03BA08

ATC

ciclesonide; inhalant

2.7

107.4

646

2584

WX892

NOMESCO Finland

Monitored bed care

2.6

106.1

695

2898

R03AK08

ATC

formoterol and beclometasone; inhalant

3.4

104.9

394

1207

L04AD01

ATC

ciclosporin; systemic

5.6

103.4

198

361

J43.9

ICD-10 Finland

Emphysema, unspecified

5.0

102.8

227

470

J01MA12

ATC

levofloxacin; systemic

2.0

102.7

1453

8302

R99

ICPC

Respiratory disease other

4.9

102.7

232

490

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.9

101.4

1871

11672

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

4.8

100.7

232

498

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

5.3

98.5

202

392

J67.9

ICD-10 Finland

Hypersensitivity pneumonitis due to unspecified organic dust

29.9

98.3

ZX108

NOMESCO Finland

Inhalation

8.9

97.5

122

140

R4110

NOMESCO Finland

Physiotherapy

1.8

97.2

1903

12064

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.9

95.3

1498

8840

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

3.4

94.8

356

1089

L88

ICPC

Rheumatoid/seropositive arthritis

3.4

91.7

354

1102

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

4.2

88.9

240

584

5150X

ICD-9 Finland

Postinflammatory pulmonary fibrosis[FIBROSIS PULMONUM E CAUSA IGNOTA]

231.0

88.7

J82

ICD-10 Finland

Pulmonary eosinophilia, not elsewhere classified

14.9

87.9

R04.2

ICD-10 Finland

Haemoptysis

3.1

87.7

388

1310

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.4

87.1

667

2978

TPH04

NOMESCO Finland

Cathetrisation of vein

1.8

86.0

1573

9696

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.7

84.9

477

1835

WW200

NOMESCO Finland

Immunization

4.0

84.9

251

653

R50.9

ICD-10 Finland

Fever, unspecified

2.0

84.1

1086

5961

R81

ICPC

Pneumonia

3.1

83.8

369

1242

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.8

83.6

1850

12054

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.7

83.1

479

1867

Z01.8

ICD-10 Finland

Other specified special examinations

1.8

81.8

1497

9205

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.7

81.4

2030

13662

L04AD02

ATC

tacrolimus; systemic

7.6

81.3

116

156

R28

ICPC

Limited function/disability (R)

5.0

80.8

177

364

UGC18

NOMESCO Finland

Flexible bronchoscopy with biopsy of lung

8.6

80.3

103

122

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

6.7

79.3

127

194

J01AA02

ATC

doxycycline; systemic

1.8

79.2

4617

38930

I50.9

ICD-10 Finland

Heart failure, unspecified

1.9

78.9

1316

7849

R05

ICPC

Cough

1.8

77.8

1551

9765

XG466

NOMESCO Finland

Sleep oxymetry

3.4

77.5

289

879

GX2C5

NOMESCO Finland

Short-lasting oximetry

8.8

75.4

110

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

74.9

2929

22051

XX9XE

NOMESCO Finland

Other ultrasound examination

7.7

74.6

105

139

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

3.4

73.2

276

845

J45.9

ICD-10 Finland

Asthma, unspecified

1.8

71.5

1236

7428

J01FA06

ATC

roxithromycin; oral

1.6

70.9

2332

16734

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.5

70.8

484

2045

GDA10

NOMESCO Finland

Biopsy of lung

15.9

70.1

N02AA01

ATC

morphine; systemic, rectal

3.6

69.1

234

668

XX2RW, ,

NOMESCO Finland

4.8

68.1

157

337

WX726

NOMESCO Finland

High-flow oxygen therapy

15.8

67.5

H02AB07

ATC

prednisone; oral

1.9

66.5

931

5215

L04AA24

ATC

abatacept; parenteral

11.4

66.4

J45.1

ICD-10 Finland

Nonallergic asthma

2.3

66.3

521

2343

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

5.9

66.1

120

208

D86.0

ICD-10 Finland

Sarcoidosis of lung

5.4

64.0

128

243

M34.9

ICD-10 Finland

Systemic sclerosis, unspecified

12.8

63.1

F1246, ,

NOMESCO Finland

19.0

62.3

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.8

60.0

1101

6695

XW5WT

NOMESCO Finland

Other blood specimen with radiologicl guidance

15.4

59.7

ZXE00

NOMESCO Finland

One hour or less

1.6

58.9

2248

16516

I27.8

ICD-10 Finland

Other specified pulmonary heart diseases

11.2

58.8

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

3.4

58.6

215

647

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

2.4

58.3

442

1953

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.9

58.3

848

4796

NH3EA

NOMESCO Finland

Feet X-ray examination with load

4.0

58.1

166

421

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

58.1

2190

16031

Z3226

NOMESCO Finland

Physiotherapist

1.7

57.3

1150

7167

ZX120

NOMESCO Finland

Intravenous

2.0

57.1

660

3448

J01CA04

ATC

amoxicillin; systemic

1.7

57.0

4527

39153

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

20.6

56.6

L04AA01

ATC

[U] ciclosporin

4.8

56.2

129

276

N02AX02

ATC

tramadol; systemic, rectal

1.5

56.0

2652

20380

J43.8

ICD-10 Finland

Other emphysema

9.2

56.0

I27.9

ICD-10 Finland

Pulmonary heart disease, unspecified

7.7

55.5

103

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.8

53.0

929

5556

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.8

52.6

849

4949

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.9

52.6

684

3720

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

3.5

52.4

180

519

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.8

52.3

903

5373

Z2221

NOMESCO Finland

Medical doctor

1.6

52.2

1572

10854

L04AB01

ATC

etanercept; parenteral

4.8

51.5

118

252

M05BA07

ATC

risedronic acid; oral

2.9

51.5

250

887

M01CB01

ATC

sodium aurothiomalate; parenteral

4.4

51.3

129

297

XG474

NOMESCO Finland

Exhalation nntrogen oxide

3.4

50.8

183

544

M34.1

ICD-10 Finland

CR(E)ST syndrome

8.9

50.1

J84

ICD-10 Finland

Other interstitial pulmonary diseases

257.6

50.1

R5140

NOMESCO Finland

Monitoring the use of the aid

1.9

49.8

734

4156

R03AK07

ATC

formoterol and budesonide; inhalant

1.7

49.1

1111

7124

I27.2

ICD-10 Finland

Other secondary pulmonary hypertension

6.2

48.8

135

A03

ICPC

Fever

1.8

48.7

828

4897

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.9

48.6

684

3813

C07AB07

ATC

bisoprolol; oral

1.5

48.5

3300

27042

F2680, ,

NOMESCO Finland

13.7

48.5

A02BC01

ATC

omeprazole; systemic

1.6

48.0

1691

12067

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.5

47.0

1788

12967

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.0

46.5

554

2917

Z3231

NOMESCO Finland

Registered nurse

1.6

46.5

1664

11902

Z51.5

ICD-10 Finland

Palliative care

1.8

45.9

743

4323

GX2D5

NOMESCO Finland

Sleep oximetry

6.6

45.4

112

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.5

44.9

282

1142

L04AB04

ATC

adalimumab; parenteral

3.8

44.3

135

359

JN4AD

NOMESCO Finland

Body CT examination

1.7

44.2

856

5246

J99.0*M05.1

ICD-10 Finland

Rheumatoid lung disease

64.3

44.2

A02BC05

ATC

esomeprazole; systemic

1.5

44.1

2315

17893

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.7

43.8

885

5487

XJC10

NOMESCO Finland

Oesophageal pH monitoring

6.7

43.7

104

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.6

43.1

1179

7900

A07AA02

ATC

nystatin; oral

2.1

43.0

418

2042

J80

ICD-10 Finland

Adult respiratory distress syndrome

8.1

42.6

XPX04

NOMESCO Finland

Angioscopy

10.8

42.6

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

3.6

42.4

144

412

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.6

42.4

1426

10024

I50.0

ICD-10 Finland

Congestive heart failure

1.8

42.3

651

3725

J12.8

ICD-10 Finland

Other viral pneumonia

4.8

42.2

200

R03BA02

ATC

budesonide; inhalant

1.7

42.1

982

6320

XG499

NOMESCO Finland

Other fysiological examination of respiatory function

8.9

41.9

J92.9

ICD-10 Finland

Pleural plaque without asbestos

3.8

41.8

127

337

TPH07

NOMESCO Finland

Cathetrisation of artery

1.7

41.7

812

4977

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.5

41.2

275

1145

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.0

40.8

477

2491

J01FA10

ATC

azithromycin; systemic

1.4

40.6

2728

21989

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

6.6

40.3

100

J70.0

ICD-10 Finland

Acute pulmonary manifestations due to radiation

10.8

40.0

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

39.9

2440

19307

M34.0

ICD-10 Finland

Progressive systemic sclerosis

14.5

39.9

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.8

39.8

200

723

Z57.2

ICD-10 Finland

Occupational exposure to dust

7.1

39.3

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.0

39.2

450

2334

WZC30

NOMESCO Finland

Teaching

1.6

39.2

1034

6850

J43.2

ICD-10 Finland

Centrilobular emphysema

7.0

38.9

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.7

38.9

838

5273

G47.3

ICD-10 Finland

Sleep apnoea

1.5

38.9

1300

9098

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.4

38.8

276

1183

J70.2

ICD-10 Finland

Acute drug-induced interstitial lung disorders

9.6

38.6

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.8

38.2

649

3820

R03BA05

ATC

fluticasone; inhalant

1.6

38.2

964

6314

M35.1

ICD-10 Finland

Other overlap syndromes

6.9

37.7

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

3.3

37.2

142

438

XW000

NOMESCO Finland

Bone marrow biopsy

2.2

37.2

318

1475

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

4.5

36.6

200

D07AC01

ATC

betamethasone; topical

1.4

36.6

2066

16036

R03BA01

ATC

beclometasone; inhalant

1.7

36.5

806

5099

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.8

36.1

564

3236

GDB11

NOMESCO Finland

Thoracoscopic wedge resection of lung

5.0

36.0

159

WZA10

NOMESCO Finland

Extensive medical or dental certificate

4.1

35.6

238

WX725

NOMESCO Finland

Noninvasive ventilation

2.1

35.4

357

1765

M05.1

ICD-10 Finland

Rheumatoid lung disease

67.0

35.0

XF400

NOMESCO Finland

ECG with 12 standard connections

1.6

35.0

1031

6995

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

2.9

34.9

168

594

GD2SN

NOMESCO Finland

Lung ventilation SPECT

4.8

34.5

165

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

3.1

34.5

143

464

M13.9

ICD-10 Finland

Arthritis, unspecified

1.9

34.1

444

2403

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

3.9

34.0

101

264

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

3.8

33.9

104

278

L01AA01

ATC

cyclophosphamide; systemic

5.9

33.8

102

R06AE07

ATC

cetirizine; oral

1.4

33.4

2140

16919

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

10.3

33.3

M35.8

ICD-10 Finland

Other specified systemic involvement of connective tissue

12.9

33.1

J96.0

ICD-10 Finland

Acute respiratory failure

3.3

33.0

125

384

J99.1

ICD-10 Finland

Respiratory disorders in other diffuse connective tissue disorders

90.6

32.7

ZYY98

NOMESCO Finland

Missed treatment contact, no notification given by patient

7.8

32.7

E0000UV, ,

ATC

1.4

32.7

2243

17923

J01FF01

ATC

clindamycin; systemic

1.5

32.6

1488

11046

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.2

32.5

292

1381

J94.1

ICD-10 Finland

Fibrothorax

49.0

32.5

D86.2

ICD-10 Finland

Sarcoidosis of lung with sarcoidosis of lymph nodes

4.7

32.4

162

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

5.5

32.2

114

J20

ICD-10 Finland

Acute bronchitis

1.8

32.2

560

3314

XF600

NOMESCO Finland

Bloodpressure measurement

1.9

31.8

415

2247

1CX01, ,

NOMESCO Finland

12.5

31.5

ZYC05

NOMESCO Finland

Non-real-time text-based remote communication

3.7

31.3

100

275

A02BC03

ATC

lansoprazole; oral

1.4

31.3

1652

12584

J99.1*M35.0

ICD-10 Finland

Respiratory disorders in sicca syndrome [Sjögren]

110.6

30.7

XJC02

NOMESCO Finland

Mesurement of oesophageal pressure and pressure profile of lower oesophageal sphincter

6.3

30.4

M05

ICD-10 Finland

Seropositive rheumatoid arthritis

4.3

30.4

179

J99.0

ICD-10 Finland

Rheumatoid lung disease

304.0

29.8

GD1RA

NOMESCO Finland

Dynamic X-ray examination of respiratory organs with convetional X-ray picture

28.8

29.8

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

29.6

2253

18230

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.0

29.5

309

1550

WX722

NOMESCO Finland

PEEP

2.1

29.4

302

1504

M81.4

ICD-10 Finland

Drug-induced osteoporosis

5.3

29.3

113

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.9

29.0

407

2255

WZC00

NOMESCO Finland

Treatment plan or consultation

1.4

28.8

1988

15810

J67.0

ICD-10 Finland

Farmer lung

9.5

28.8

M04AA01

ATC

allopurinol; systemic

1.5

28.5

965

6721

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

28.4

1764

13776

XG460

NOMESCO Finland

Short time oxymetry

3.0

28.4

127

431

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

28.2

2004

16001

C01DA14

ATC

isosorbide mononitrate; oral

1.5

28.1

1206

8808

R03DC03

ATC

montelukast; oral

1.6

28.1

782

5214

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.1

28.0

266

1285

R4190

NOMESCO Finland

Nutritional therapy

2.3

28.0

220

985

J01DB01

ATC

cefalexin; oral

1.4

27.9

4563

41520

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

2.2

27.9

233

1070

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

27.7

2129

17205

1XC02, ,

NOMESCO Finland

4.6

27.5

143

7140A

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]

3.4

27.3

287

Z2446

NOMESCO Finland

Social worker

1.9

27.0

339

1810

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

4.6

27.0

141

J01FA09

ATC

clarithromycin; systemic

1.4

27.0

1474

11241

2AX04, ,

NOMESCO Finland

62.3

26.9

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

26.9

2450

20301

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

2.5

26.8

174

716

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

3.3

26.8

101

310

N02BE01

ATC

paracetamol; systemic, rectal

1.5

26.8

5110

47610

JN4BD

NOMESCO Finland

Extensive body CT

1.6

26.6

666

4328

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.6

26.5

740

4936

AN1

Coronary angiography

1.5

26.4

802

5451

A01AB09

ATC

miconazole; local oral

1.7

26.2

486

2924

GAA31

NOMESCO Finland

Thoracoscopy

5.8

26.1

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.6

26.1

599

3810

SPAT1325

SPAT

Vaccination

1.4

26.0

2014

16253

TGD00

NOMESCO Finland

Needle biopsy of lung

4.9

25.9

118

R29

ICPC

Respiratory symptom/complaint other

1.8

25.9

381

2142

M33.2

ICD-10 Finland

Polymyositis

7.4

25.9

J05AB11

ATC

valaciclovir; oral

1.6

25.8

764

5160

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.4

25.7

1339

10112

H02AB04

ATC

methylprednisolone; systemic

1.5

25.6

780

5300

XX2XT

NOMESCO Finland

Other injection with other radiological guidance

7.1

25.4

XQ841

NOMESCO Finland

Examination of dermatosis with microscope

25.1

25.2

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

2.7

25.2

141

540

J13

ICD-10 Finland

Pneumonia due to Streptococcus pneumoniae

3.8

25.2

197

N03AX16

ATC

[U] pregabalin

1.4

25.1

1261

9456

R01AD09

ATC

mometasone; nasal

1.3

25.0

2093

17063

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

25.0

2067

16820

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

2.5

24.9

157

637

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.3

24.9

195

872

R06.2

ICD-10 Finland

Wheezing

2.1

24.9

250

1234

J18

ICD-10 Finland

Pneumonia, organism unspecified

3.6

24.9

226

XG405

NOMESCO Finland

Education on PEF monitoring

3.0

24.8

107

356

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

24.8

1009

7274

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

24.8

3681

32607

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.8

24.8

354

1972

I73.0

ICD-10 Finland

Raynaud syndrome

3.2

24.6

306

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.0

24.4

266

1353

J01FA15

ATC

telithromycin; oral

1.7

24.4

473

2879

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

1.8

24.4

355

1989

WX408

NOMESCO Finland

General anesthesy, balanced

1.4

24.3

1399

10733

R03AK03

ATC

[U] fenoterol and ipratropium bromide

1.8

24.1

377

2158

SPAT1262

SPAT

Handing over of treatment supplies

1.4

24.0

1074

7880

B25.9

ICD-10 Finland

Cytomegaloviral disease, unspecified

8.0

23.9

5BA08, ,

NOMESCO Finland

4.7

23.5

116

5AB14, ,

NOMESCO Finland

19.6

23.4

J98.4

ICD-10 Finland

Other disorders of lung

7.5

23.3

RK320, ,

NOMESCO Finland

3.8

23.2

190

RK110, ,

NOMESCO Finland

4.0

23.1

168

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.5

23.1

141

564

N02AA05

ATC

oxycodone; systemic

1.4

23.0

1229

9299

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

1.9

23.0

278

1466

H02AB09

ATC

hydrocortisone; systemic

2.5

22.8

144

585

TNB11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in shoulder joint

4.6

22.8

119

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.5

22.8

864

6137

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

22.7

1060

7829

ZXA10

NOMESCO Finland

Bilateral

1.4

22.7

1067

7892

A10AC01

ATC

insulin (human); parenteral

1.7

22.7

452

2770

GD1UN

NOMESCO Finland

Lung circulation SPECT

4.4

22.7

132

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

22.6

1509

11842

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.9

22.5

293

1583

L04AB06

ATC

golimumab; parenteral

4.9

22.4

101

J93.1

ICD-10 Finland

Other spontaneous pneumothorax

3.6

22.4

204

ZXA00

NOMESCO Finland

Right side

1.4

22.4

1526

12010

J15.8

ICD-10 Finland

Other bacterial pneumonia

3.7

22.4

195

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.7

22.2

476

2972

UJF32

NOMESCO Finland

Coloscopy

1.4

22.2

1562

12351

J93.8

ICD-10 Finland

Other pneumothorax

4.7

22.1

110

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

22.1

1350

10439

5169X

ICD-9 Finland

Other alveolar and parietoalveolar pneumopathy, Unspecified alveolar and parietoalveolar pneumopathy

+∞

21.9

5163A

ICD-9 Finland

Other alveolar and parietoalveolar pneumopathy, Idiopathic fibrosing alveolitis

+∞

21.9

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

2.3

21.8

163

716

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.8

21.7

306

1697

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.5

21.7

691

4732

L04AC07

ATC

tocilizumab; parenteral

6.7

21.6

3A006, ,

NOMESCO Finland

220.8

21.6

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.8

21.6

345

1987

M31.3

ICD-10 Finland

Wegener granulomatosis

5.7

21.6

Z3229

NOMESCO Finland

Other healthcare associate professional

1.6

21.6

495

3144

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.4

21.5

1368

10636

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

2.7

21.5

115

431

318

Kela drug reimbursment

Teriparatide

4.5

21.2

114

D07AC13

ATC

mometasone; topical

1.4

21.2

1489

11758

GX1L5

NOMESCO Finland

Exhaled nitric oxide analysis

4.2

21.2

135

M06.8

ICD-10 Finland

Other specified rheumatoid arthritis

4.0

21.0

153

JN3AD

NOMESCO Finland

Abdominal CT examination

1.5

21.0

770

5426

J06BA01

ATC

immunoglobulins, normal human, for extravascular adm.; systemic

16.6

20.9

H05AA02

ATC

teriparatide; parenteral

4.7

20.8

100

120

Kela drug reimbursment

Hypogammaglobulinaemia

16.9

20.4

WPA11

NOMESCO Finland

Developing a plan for palliative care

5.6

20.4

N05CF01

ATC

zopiclone; oral

1.3

20.3

1814

14822

R03AK11

ATC

formoterol and fluticasone; inhalant

2.4

20.3

141

600

WX002

NOMESCO Finland

Sedation and analgesia

1.4

20.2

1090

8238

ZXE40

NOMESCO Finland

More than seven and less than nine hours

2.3

20.2

152

669

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

2.3

20.2

151

663

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

2.5

20.1

125

505

R74

ICPC

Upper respiratory infection acute

1.4

20.0

1202

9250

I27.0

ICD-10 Finland

Primary pulmonary hypertension

7.6

19.9

J45.8

ICD-10 Finland

Mixed asthma

2.1

19.8

177

837

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.1

19.8

193

944

A10AB05

ATC

insulin aspart; parenteral

1.6

19.7

445

2813

GD1AA, ,

SPAT

1.5

19.7

635

4355

M34.8

ICD-10 Finland

Other forms of systemic sclerosis

29.0

19.6

J05AB01

ATC

aciclovir; systemic

1.4

19.6

1093

8304

WX872

NOMESCO Finland

Intensive care

1.8

19.5

327

1910

L01CB

ATC

Podophyllotoxin derivatives

6.8

19.5

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

3.1

19.3

261

B02.9

ICD-10 Finland

Zoster without complication

1.6

19.3

424

2664

132

Kela drug reimbursment

Sarcoidosis

4.0

19.2

132

R76.0

ICD-10 Finland

Raised antibody titre

6.5

19.2

SPAT1263

SPAT

Sampling

1.3

19.2

2194

18499

J18.1

ICD-10 Finland

Lobar pneumonia, unspecified

3.0

19.1

294

R01AD12

ATC

fluticasone furoate; nasal

1.4

19.1

1265

9876

RS123, ,

NOMESCO Finland

14.8

18.9

N03AX12

ATC

[U] gabapentin; oral

1.4

18.7

849

6219

B01AA03

ATC

warfarin; systemic

1.3

18.6

1325

10451

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.7

18.6

343

2059

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.5

18.5

567

3846

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.1

18.5

181

887

R94.2

ICD-10 Finland

Abnormal results of pulmonary function studies

3.9

18.4

136

NDG30

NOMESCO Finland

Fusion of wrist, total

4.6

18.4

J46

ICD-10 Finland

Status asthmaticus

2.2

18.3

159

743

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.8

18.3

298

1727

R03BB07

ATC

umeclidinium bromide; inhalant

3.4

18.3

198

R01AD08

ATC

fluticasone; nasal

1.3

18.2

1264

9924

WPA13

NOMESCO Finland

Palliative consultation

4.1

18.2

124

XA421

NOMESCO Finland

Nocturnal polygraphy

4.8

18.2

FXD00

NOMESCO Finland

Use of ECHLA without concurrent surgical procedure

25.1

18.2

J01MA02

ATC

ciprofloxacin; systemic

1.3

18.1

2248

19110

L04AA17

ATC

[U] adalimumab

6.1

18.1

GDA97

NOMESCO Finland

Other thoracoscopic incision, excision of lesion or repair of lung

52.7

17.9

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.3

17.9

132

577

XX6XT

NOMESCO Finland

Other intravascular therapy with radiological guidance

5.5

17.9

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.7

17.8

307

1809

M25.5

ICD-10 Finland

Pain in joint

1.3

17.8

1526

12353

AA3AI

NOMESCO Finland

Cone beam CT of facial bones

3.6

17.7

163

M05BA06

ATC

ibandronic acid; systemic

2.4

17.7

123

524

A28

ICPC

Limited function/disability NOS

1.3

17.6

1236

9716

ZXE20

NOMESCO Finland

More than three and less than five hours

1.4

17.6

761

5523

UJF30

NOMESCO Finland

Ileoscopy through colon

1.5

17.6

563

3854

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.4

17.5

942

7099

J02AC01

ATC

fluconazole; systemic

1.3

17.5

1613

13176

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.6

17.5

470

3095

WX723

NOMESCO Finland

CPAP therapy

1.9

17.4

213

1130

291

Kela drug reimbursment

Tofacitinib

7.4

17.4

TNH11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in ankle joint or foot joint

3.2

17.3

205

WX402

NOMESCO Finland

General anaesthesia

1.4

17.3

1076

8303

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.6

17.2

473

3132

M05BB03

ATC

alendronic acid and colecalciferol; oral

2.2

17.2

142

651

WX882

NOMESCO Finland

High dependency care

2.0

17.1

173

859

1240

FHL

Bronchoscopy

2.9

17.0

265

A03FA01

ATC

metoclopramide; systemic, rectal

1.3

16.9

1137

8874

C09AA05

ATC

ramipril; oral

1.3

16.7

1595

13075

XF614

NOMESCO Finland

Measurement of pulmonary artery pressure

6.2

16.7

J98.9

ICD-10 Finland

Respiratory disorder, unspecified

6.2

16.7

M05BX04

ATC

denosumab; parenteral

1.6

16.7

386

2454

XQ800

NOMESCO Finland

Prick test

1.8

16.7

273

1585

XF402

NOMESCO Finland

ECG with work load test

1.5

16.6

631

4470

J02AC03

ATC

voriconazole; systemic

5.9

16.5

ZY010

NOMESCO Finland

Hospital outpatient

1.9

16.5

198

1044

J20.5

ICD-10 Finland

Acute bronchitis due to respiratory syncytial virus

3.7

16.3

139

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.2

16.3

130

588

M33.1

ICD-10 Finland

Other dermatomyositis

14.3

16.3

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.7

16.3

306

1846

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

2.1

16.3

156

759

WVA20

NOMESCO Finland

Medicine administration

2.0

16.2

165

820

R07.4

ICD-10 Finland

Chest pain, unspecified

1.3

16.2

1602

13188

L04AB05

ATC

certolizumab pegol; parenteral

5.8

16.2

R03AC03

ATC

terbutaline; inhalant

1.4

16.1

651

4661

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.2

16.1

134

617

M01CB03

ATC

auranofin; oral

3.5

16.0

155

TGW99

NOMESCO Finland

Other minor procedure in thoracic surgery

6.0

16.0

GDA98

NOMESCO Finland

Other bronchoscopic incision, excision of lesion or repair of lung

3.5

16.0

160

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.6

16.0

410

2673

ZXA05

NOMESCO Finland

Left side

1.3

15.9

1366

11028

R4120

NOMESCO Finland

Occupational therapy

1.6

15.8

337

2099

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.0

15.8

182

946

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

15.7

1742

14535

C03DA01

ATC

spironolactone; oral

1.4

15.7

764

5654

M31.9

ICD-10 Finland

Necrotizing vasculopathy, unspecified

6.6

15.7

GD1CQ

NOMESCO Finland

Lung circulation SPECT with low dose CT

6.6

15.7

J01XB01

ATC

colistin; inhalant, parenteral

33.4

15.7

ZXD05

NOMESCO Finland

Urgent procedure

1.3

15.6

1548

12738

M10.9

ICD-10 Finland

Gout, unspecified

1.5

15.5

478

3243

AK3

BLTX (both lung transplants)

160.4

15.5

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

1.7

15.5

278

1657

H19.3*M35.0

ICD-10 Finland

Keratoconjunctivitis sicca

4.9

15.4

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.6

15.4

419

2766

ZX114

NOMESCO Finland

Intramuscular

2.8

15.4

280

NK5AT

NOMESCO Finland

Joint injection with ultrasound guidance not elsewhere classified

3.7

15.4

131

M33.9

ICD-10 Finland

Dermatopolymyositis, unspecified

12.3

15.3

WX302

NOMESCO Finland

Thoracal epidural anesthesy

1.7

15.3

297

1807

H26.3

ICD-10 Finland

Drug-induced cataract

4.0

15.3

109

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.6

15.2

409

2693

J01DA01

ATC

[U] cefalexin

1.2

15.2

3170

28431

TNG10

NOMESCO Finland

Puncture of knee

2.9

15.1

244

J99.1*M33.2

ICD-10 Finland

Respiratory disorders in polymyositis

45.1

15.0

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

15.0

1575

13036

NHG76

NOMESCO Finland

Arthroplasty of other tarsometatarsal joint

2.6

14.9

336

ZYC01

NOMESCO Finland

Remote contact by phone

1.7

14.9

290

1765

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.5

14.9

502

3470

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

1.8

14.8

218

1227

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

14.7

926

7139

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

3.1

14.6

190

L95

ICPC

Osteoporosis

1.8

14.6

228

1307

R03AC13

ATC

formoterol; inhalant

1.7

14.5

265

1586

XF622

NOMESCO Finland

Measurement of minute volume of heart

4.7

14.4

ZYB02

NOMESCO Finland

Outreach service at unit of another specialty

5.8

14.4

R24

ICPC

Haemoptysis

3.1

14.4

187

C10AA03

ATC

pravastatin; oral

1.5

14.3

451

3074

E000001, ,

ATC

1.3

14.3

909

7019

R2110

NOMESCO Finland

Giving the first information

1.7

14.3

284

1740

B01AC04

ATC

clopidogrel; oral

1.3

14.2

1108

8811

U09.9

ICD-10 Finland

Post COVID-19 condition, unspecified

3.8

14.2

115

XX1VW

NOMESCO Finland

Written report from radiologist

3.2

14.2

173

A40.3

ICD-10 Finland

Sepsis due to Streptococcus pneumoniae

3.2

14.2

168

N18.8

ICD-10 Finland

Other chronic renal failure

1.9

14.1

165

862

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

3.1

14.1

179

C08CA05

ATC

nifedipine; systemic

1.6

14.1

364

2377

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

1.8

14.0

221

1269

3AC01, ,

NOMESCO Finland

3.0

14.0

200

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.6

14.0

299

1864

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

14.0

2257

19609

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.3

14.0

1102

8774

NG1DA

NOMESCO Finland

X-ray of knees

2.3

14.0

109

489

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.3

14.0

1498

12414

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.5

13.9

452

3099

R01AD58

ATC

fluticasone, combinations; nasal

1.3

13.9

912

7070

M80.8

ICD-10 Finland

Other osteoporosis with pathological fracture

3.8

13.9

112

Angiography of the heart and coronary arteries

1.5

13.9

428

2903

7931A

ICD-9 Finland

Nonspecific abnormal findings on radiological and other examination of body structure, Lung field

4.1

13.9

D07AB08

ATC

desonide; topical

1.5

13.9

514

3619

D07AD01

ATC

clobetasol; topical

1.4

13.9

817

6234

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.4

13.8

633

4632

M54.5

ICD-10 Finland

Low back pain

1.3

13.8

1722

14532

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

1.9

13.7

178

963

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.8

13.7

217

1249

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.8

13.7

219

1264

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

3.4

13.7

137

SBA10

NOMESCO Finland

Measurement of salivary flow rate

2.9

13.6

209

B01AB05

ATC

enoxaparin; parenteral

1.3

13.6

1747

14785

J17.1*B25.0

ICD-10 Finland

Cytomegaloviral pneumonitis

75.3

13.6

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

2.4

13.6

401

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

1.9

13.5

177

961

SPAT1255

SPAT

Intravenous administration of medicine

1.5

13.5

386

2577

WX740

NOMESCO Finland

Nitrogen oxide therapy

10.9

13.5

WX720

NOMESCO Finland

Own respiration

1.7

13.5

257

1558

L04AA37

ATC

[U] baricitinib

10.0

13.4

71238

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides alia definita

3.0

13.4

200

-1, ,

NOMESCO Finland

1.3

13.4

1402

11575

L04AA29

ATC

[U] tofacitinib

6.1

13.4

XX7LW, ,

NOMESCO Finland

6.1

13.4

C02KX04

ATC

macitentan; oral

18.2

13.3

TGE00

NOMESCO Finland

Needle biopsy of mediastinum

4.3

13.3

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

2.5

13.2

321

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.6

13.2

298

1886

WX727

NOMESCO Finland

Estimation of exercise oxygen therapy

40.1

13.1

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

2.2

13.1

114

535

NDL52

NOMESCO Finland

Tenosynovectomy of hand

3.4

13.1

136

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

2.3

13.1

426

ZXX04

NOMESCO Finland

Extent of procedure, 4 units

4.3

13.1

JC2AB

NOMESCO Finland

Oesophagus X-ray examination with contrast

2.6

13.0

276

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.8

13.0

202

1156

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.7

13.0

221

1298

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

2.4

13.0

366

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

2.5

13.0

318

293

Kela drug reimbursment

Baricitinib

10.0

12.9

3006

Kela drug reimbursment

Baricitinib

9.3

12.9

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.5

12.9

356

2360

NJ3CG

NOMESCO Finland

Extensive MRI examination of extremities with median high magnet

4.3

12.8

R03BB01

ATC

ipratropium bromide; inhalant

1.7

12.8

239

1440

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.5

12.7

423

2914

C10AA01

ATC

simvastatin; oral

1.2

12.7

2678

23857

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.2

12.6

1723

14658

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

1.9

12.6

146

762

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.5

12.6

459

3223

R04.0

ICD-10 Finland

Epistaxis

1.5

12.5

468

3299

R03AC12

ATC

salmeterol; inhalant

1.7

12.5

248

1519

B01AB04

ATC

dalteparin; parenteral

1.6

12.5

278

1753

A02BA03

ATC

famotidine; systemic

1.7

12.5

213

1253

T86.8

ICD-10 Finland

Failure and rejection of other transplanted organs and tissues

24.3

12.4

ZX197, ,

NOMESCO Finland

20.1

12.4

R03AC19

ATC

olodaterol

3.8

12.4

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.6

12.3

308

1996

R03BB06

ATC

glycopyrronium bromide; inhalant

3.8

12.3

D64.9

ICD-10 Finland

Anaemia, unspecified

1.4

12.3

705

5350

TK800

NOMESCO Finland

Hemodialysis

2.0

12.3

125

624

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.2

12.2

2577

22924

XX3DW

NOMESCO Finland

Time consuming IT work

1.4

12.2

587

4330

E84.0

ICD-10 Finland

Cystic fibrosis with pulmonary manifestations

37.6

12.2

J94.9

ICD-10 Finland

Pleural condition, unspecified

3.4

12.2

123

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

3.2

12.1

143

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

12.1

2080

18118

R04

ICPC

Breathing problem other

1.7

12.1

198

1152

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

1.8

12.0

164

904

A02BA02

ATC

ranitidine; systemic

1.3

12.0

1046

8426

ED1AA

NOMESCO Finland

Mandibular X-ray examination

3.3

11.9

130

J45

ICD-10 Finland

Asthma

1.4

11.9

451

3190

J18.0

ICD-10 Finland

Bronchopneumonia, unspecified

2.3

11.8

369

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.2

11.8

2159

18916

H25.1

ICD-10 Finland

Senile nuclear cataract

1.2

11.7

1845

15908

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.3

11.7

847

6649

D11

ICPC

Diarrhoea

1.4

11.7

474

3391

XX1AW

NOMESCO Finland

Written report from X-ray examination without contrast peformed elsewhere

3.9

11.7

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

3.6

11.7

107

K02.1

ICD-10 Finland

Caries of dentine

1.2

11.6

2662

23828

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

1.9

11.6

144

769

J99.1*M34.8

ICD-10 Finland

Respiratory disorders in systemic: sclerosis

30.1

11.6

J01GB01

ATC

tobramycin; inhalant, parenteral

12.5

11.6

E84.9

ICD-10 Finland

Cystic fibrosis, unspecified

65.1

11.6

A46

ICD-10 Finland

Erysipelas

1.3

11.6

866

6831

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

2.2

11.5

437

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.7

11.5

227

1388

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

2.6

11.5

258

ZX100

NOMESCO Finland

Oral

2.3

11.5

380

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.0

11.5

116

577

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.5

11.5

364

2485

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

2.5

11.4

271

B37.0

ICD-10 Finland

Candidal stomatitis

2.7

11.4

219

J94.8

ICD-10 Finland

Other specified pleural conditions

2.1

11.4

109

532

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

3.2

11.3

139

J93.0

ICD-10 Finland

Spontaneous tension pneumothorax

5.4

11.3

J12.1

ICD-10 Finland

Respiratory syncytial virus pneumonia

3.2

11.3

134

L03

ICPC

Low back symptom/complaint

1.3

11.3

1360

11381

N07BA03

ATC

varenicline; oral

1.8

11.3

174

995

J18.8

ICD-10 Finland

Other pneumonia, organism unspecified

3.5

11.3

105

A07EC02

ATC

mesalazine; oral, rectal

1.6

11.3

228

1405

J99.1*M31.3

ICD-10 Finland

Respiratory disorders in Wegener's granulomatosis

10.5

11.2

B44.1

ICD-10 Finland

Other pulmonary aspergillosis

10.5

11.2

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

1.8

11.2

158

879

J42

ICD-10 Finland

Unspecified chronic bronchitis

2.4

11.2

322

TNG11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in knee

2.9

11.2

177

A06AC01

ATC

ispaghula (psylla seeds); oral

1.2

11.2

1389

11665

H03AA01

ATC

levothyroxine sodium; systemic

1.3

11.1

1064

8670

E000002, ,

ATC

1.4

11.0

443

3165

RK120, ,

NOMESCO Finland

4.6

10.9

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

1.7

10.9

195

1164

6BA02, ,

NOMESCO Finland

5.4

10.9

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

1.8

10.8

158

889

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

2.3

10.8

346

FXF00

NOMESCO Finland

Decannulation after ECHLA or ECLA

21.5

10.7

A41.9

ICD-10 Finland

Sepsis, unspecified

1.7

10.6

210

1286

RS221, ,

NOMESCO Finland

2.4

10.6

287

J99.1*M32.1

ICD-10 Finland

Respiratory disorders in systemic: lupus erythematosus

60.1

10.6

S18

ICPC

Laceration/cut

1.2

10.6

2615

23498

D07XC01

ATC

betamethasone; topical

1.4

10.6

610

4629

C10AA05

ATC

atorvastatin; oral

1.2

10.5

2546

22831

I50.1

ICD-10 Finland

Left ventricular failure

1.5

10.5

320

2166

G30.1

ICD-10 Finland

Alzheimer disease with late onset

0.6

10.5

189

3064

S01GX01

ATC

cromoglicic acid; ophthalmic

1.3

10.5

741

5793

J96.9

ICD-10 Finland

Respiratory failure, unspecified

2.8

10.5

178

A04

ICPC

Weakness/tiredness general

1.3

10.5

814

6448

SAA02

NOMESCO Finland

Basic examination of mouth

1.2

10.5

3018

27496

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

2.6

10.5

235

B01AF02

ATC

apixaban; oral

1.3

10.5

871

6963

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.6

10.4

270

1766

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

2.2

10.4

410

B07.9

ICD-10 Finland

Verruca simplex

1.8

10.4

148

827

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.6

10.4

214

1325

WX203

NOMESCO Finland

Infraclavicular plexus blockade

2.0

10.4

109

551

M32.8

ICD-10 Finland

Other forms of systemic lupus erythematosus

5.4

10.4

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

2.6

10.4

213

SPAT1260

SPAT

Consultation of another employee

1.3

10.4

887

7117

Z71.8

ICD-10 Finland

Other specified counselling

1.2

10.4

1559

13349

J67.8

ICD-10 Finland

Hypersensitivity pneumonitis due to other organic dusts

32.6

10.3

XF404

NOMESCO Finland

Ambulatory ECG

1.4

10.3

482

3539

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.4

10.3

497

3668

XJC00

NOMESCO Finland

Oesophageal manometry

3.9

10.3

S22.2

ICD-10 Finland

Fracture of sternum

3.1

10.3

132

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.2

10.3

380

K31.8

ICD-10 Finland

Other specified diseases of stomach and duodenum

3.2

10.3

127

NDG74

NOMESCO Finland

Fusion of first IP joint

4.4

10.2

L04AK01

ATC

leflunomide; oral

3.3

10.2

112

QC6S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in hand

9.6

10.2

J98.2

ICD-10 Finland

Interstitial emphysema

9.6

10.2

N06DX01

ATC

memantine; oral

0.7

10.2

265

3956

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

1.7

10.2

166

965

A31.0

ICD-10 Finland

Pulmonary mycobacterial infection

4.0

10.2

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.2

10.2

1468

12508

R03AL03

ATC

vilanterol and umeclidinium bromide; inhalant

2.2

10.2

407

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.6

10.2

242

1552

J12.9

ICD-10 Finland

Viral pneumonia, unspecified

3.1

10.1

128

GD5CD

NOMESCO Finland

Thorax and upper abdomen combined very extensive CT examination of

3.2

10.1

123

NDF10

NOMESCO Finland

Synovectomy of wrist

5.3

10.1

R52.0

ICD-10 Finland

Acute pain

1.8

10.0

143

800

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.4

10.0

395

2814

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

4.6

10.0

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

2.5

10.0

241

H04.10

ICD-10 Finland

Dry eye syndrome

1.4

10.0

534

4007

J37.0

ICD-10 Finland

Chronic laryngitis

1.8

10.0

157

905

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.3

9.9

762

6029

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.4

9.9

376

2661

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

2.0

9.9

479

D05AX52

ATC

calcipotriol, combinations; topical

1.6

9.9

247

1603

TFP20

NOMESCO Finland

Cardiodefibrillation

1.4

9.9

440

3203

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

3.0

9.9

146

J93.9

ICD-10 Finland

Pneumothorax, unspecified

3.2

9.8

120

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

3.2

9.8

115

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.4

9.8

518

3878

N06DA03

ATC

rivastigmine; oral, transdermal

0.5

9.8

111

2035

R06AX27

ATC

desloratadine; oral

1.3

9.7

1068

8829

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.6

9.7

193

1185

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.0

9.7

104

530

M79.0

ICD-10 Finland

Rheumatism, unspecified

1.8

9.7

135

750

SAA01

NOMESCO Finland

Simple examination of mouth

1.2

9.7

3362

31044

M06

ICD-10 Finland

Other rheumatoid arthritis

3.0

9.7

137

M79.6

ICD-10 Finland

Pain in limb

1.2

9.7

2142

19012

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

0.5

9.7

1502

XG422

NOMESCO Finland

Time-volume spirometry with bronchodialtation

5.3

9.6

R4130

NOMESCO Finland

Speech therapy

1.8

9.6

143

812

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

1.5

9.5

288

1948

WX780

NOMESCO Finland

Remote monitoring CPAP

1.6

9.5

192

1184

DHA10

NOMESCO Finland

Biopsy of cavity of nose

2.8

9.5

160

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

2.4

9.5

247

ZX121

NOMESCO Finland

Central venous catheter

4.0

9.5

M01AE02

ATC

naproxen; oral, rectal

1.2

9.5

2621

23711

SPAT1059

SPAT

Spirometry at the office

1.5

9.5

257

1699

ZY000

NOMESCO Finland

Hospital inpatient

2.7

9.4

183

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

1.8

9.4

124

677

304

Kela drug reimbursment

Dornase alfa

100.2

9.4

R05CB13

ATC

dornase alfa (desoxyribonuclease); inhalant

100.2

9.4

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.3

9.4

662

5172

XQ848

NOMESCO Finland

Dermatological photography

1.7

9.4

162

958

Z94.3

ICD-10 Finland

Heart and lungs transplant status

30.1

9.4

2770A

ICD-9 Finland

Other and unspecified disorders of metabolism, Cystic fibrosis

+∞

9.4

WPA15

NOMESCO Finland

Palliative care consultation with the patient and loved ones

3.0

9.4

129

D02AE01

ATC

carbamide; topical

1.5

9.3

286

1940

4040, ,

NOMESCO Finland

12.3

9.3

RK220, ,

NOMESCO Finland

4.0

9.3

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.6

9.3

186

1145

TND10

NOMESCO Finland

Joint puncture, wrist or finger joint

4.7

9.3

RT271, ,

NOMESCO Finland

8.7

9.3

XX4AW, ,

NOMESCO Finland

10.7

9.3

R53

ICD-10 Finland

Malaise and fatigue

1.2

9.3

1250

10564

I26

ICD-10 Finland

Pulmonary embolism

2.5

9.3

214

M54

ICD-10 Finland

Dorsalgia

1.4

9.2

488

3655

A01AB04

ATC

amphotericin B; local oral

1.6

9.2

235

1533

L28

ICPC

Limited function/disability (L)

1.2

9.2

1133

9482

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

1.5

9.1

302

2081

OAB50, ,

SPAT

1.4

9.1

427

3137

J31.0

ICD-10 Finland

Chronic rhinitis

1.4

9.1

344

2433

M01AB05

ATC

diclofenac; systemic, rectal

1.2

9.0

3265

30167

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

1.7

9.0

151

886

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.4

9.0

412

3012

S29

ICPC

Skin symptom/complaint other

1.2

9.0

1048

8711

N06DA02

ATC

donepezil; oral

0.6

9.0

192

2990

WPA45

NOMESCO Finland

Continuous drug infusion in palliative care

4.1

9.0

T90

ICPC

Diabetes non-insulin dependent

1.2

8.9

1405

12056

P01AB01

ATC

metronidazole; oral, rectal

1.2

8.9

1796

15776

FXE00

NOMESCO Finland

Use of ECLA

24.0

8.9

S97

ICPC

Chronic ulcer skin

1.4

8.9

378

2730

M48.0

ICD-10 Finland

Spinal stenosis

1.3

8.9

714

5678

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.2

8.9

1352

11562

SBA00

NOMESCO Finland

Microbiological examinations

1.8

8.9

120

662

G04BE08

ATC

tadalafil; oral

4.3

8.9

R05FB02

ATC

cough suppressants and expectorants; systemic

1.2

8.8

1895

16735

GDA21

NOMESCO Finland

Thoracoscopic excision of lesion of lung

4.9

8.8

EBA10

NOMESCO Finland

Operative extraction of tooth

1.4

8.8

424

3127

K23.8*B37.8

ICD-10 Finland

Esophagitis caused by candidiasis

3.1

8.8

118

A11

ICPC

Chest pain NOS

1.4

8.8

459

3431

U08.9

ICD-10 Finland

Personal history of COVID-19, unspecified

4.0

8.8

WPB10

NOMESCO Finland

Making a convalescent care decision

3.1

8.8

113

N19

ICD-10 Finland

Unspecified kidney failure

1.5

8.8

233

1535

207

Kela drug reimbursment

Chronic arrhythmias

1.2

8.7

1042

8687

E000003, ,

ATC

1.6

8.7

179

1111

D05BB02

ATC

acitretin; oral

1.9

8.7

112

609

RS230, ,

NOMESCO Finland

3.2

8.6

104

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

8.6

3206

29645

M05BB04

ATC

risedronic acid, calcium and colecalciferol, sequential; oral

4.8

8.6

M32

ICD-10 Finland

Systemic lupus erythematosus

11.6

8.6

J70.4

ICD-10 Finland

Drug-induced interstitial lung disorders, unspecified

16.3

8.5

L04AC14

ATC

sarilumab; systemic

9.0

8.5

I50

ICD-10 Finland

Heart failure

1.6

8.5

198

1266

R06.8

ICD-10 Finland

Other and unspecified abnormalities of breathing

2.1

8.5

357

D89.89

ICD-10 Finland

Other specified disorders involving the immune mechanism, not elsewhere classified

27.5

8.5

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

2.1

8.5

384

N17.8

ICD-10 Finland

Other acute renal failure

2.1

8.4

391

R60.0

ICD-10 Finland

Localized oedema

1.3

8.4

706

5642

E84.8

ICD-10 Finland

Cystic fibrosis with other manifestations

90.2

8.4

RK250, ,

NOMESCO Finland

3.0

8.4

116

B34.9

ICD-10 Finland

Viral infection, unspecified

1.9

8.4

104

558

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.2

8.4

1278

10921

C81.9

ICD-10 Finland

Hodgkin lymphoma, unspecified

4.3

8.4

J01FA01

ATC

erythromycin; systemic

1.3

8.4

480

3641

SPAT1310

SPAT

Counselling related to known health issue

1.2

8.4

1540

13402

B59

ICD-10 Finland

Pneumocystosis

7.8

8.3

UGC08

NOMESCO Finland

Rigid bronchoscopy with biopsy of lung

+∞

8.3

5168X

ICD-9 Finland

Other alveolar and parietoalveolar pneumopathy, Other specified alveolar and parietoalveolar pneumopathies

+∞

8.3

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.3

8.3

583

4551

L57.0

ICD-10 Finland

Actinic keratosis

1.3

8.3

669

5319

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

2.0

8.3

455

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

2.0

8.3

414

M32.1

ICD-10 Finland

Systemic lupus erythematosus with organ or system involvement

8.5

8.3

J43.1

ICD-10 Finland

Panlobular emphysema

9.4

8.3

D72.1

ICD-10 Finland

Eosinophilia

3.5

8.2

J32.4

ICD-10 Finland

Chronic pansinusitis

2.2

8.2

309

C02KX01

ATC

bosentan; oral

14.5

8.2

UGC02

NOMESCO Finland

Rigid bronchoscopy

4.2

8.2

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

1.4

8.2

368

2685

M01AX17

ATC

nimesulide; oral

1.2

8.2

1216

10366

71239

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides NUD

2.6

8.2

174

SFA10

NOMESCO Finland

One-surface restoration

1.2

8.1

2489

22608

M31.7

ICD-10 Finland

Microscopic polyangiitis

7.5

8.1

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

1.7

8.1

138

815

M10

ICD-10 Finland

Gout

1.5

8.1

260

1783

RS220, ,

NOMESCO Finland

2.3

8.1

260

M01AH02

ATC

rofecoxib; oral

1.3

8.1

644

5115

D80.9

ICD-10 Finland

Immunodeficiency with predominantly antibody defects, unspecified

8.1

Coronary artery bypass surgery

1.7

8.1

146

877

Z31.5

ICD-10 Finland

Genetic counselling

1.6

8.1

162

1000

M02AA07

ATC

piroxicam; topical

1.2

8.0

1836

16274

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

1.8

8.0

125

720

D70.82

ICD-10 Finland

Drug-induced neutropenia

2.0

8.0

392

NHG77

NOMESCO Finland

Arthroplasty of interphalangeal tarsal joint(s)

1.8

8.0

105

574

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

1.9

8.0

102

553

I25.2

ICD-10 Finland

Old myocardial infarction

1.4

8.0

429

3221

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1.4

8.0

370

2713

R03DA04

ATC

theophylline; systemic, rectal

1.5

8.0

284

1987

C08CA02

ATC

felodipine; oral

1.3

8.0

555

4328

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

1.3

8.0

456

3457

R06AE09

ATC

levocetirizine; oral

1.3

7.9

511

3942

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.3

7.9

641

5100

K51.8

ICD-10 Finland

Other ulcerative colitis

2.2

7.9

275

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

1.6

7.9

198

1288

A15.0

ICD-10 Finland

Tuberculosis of lung, confirmed by sputum microscopy with or without culture

4.4

7.9

M35.3

ICD-10 Finland

Polymyalgia rheumatica

1.5

7.9

247

1686

G53.0

ICD-10 Finland

Postzoster neuralgia

2.5

7.9

183

N06AX11

ATC

mirtazapine; oral

1.2

7.9

1620

14225

L03AA02

ATC

filgrastim; parenteral

1.7

7.9

143

860

Z57.3

ICD-10 Finland

Occupational exposure to other air contaminants

3.9

7.9

D80.3

ICD-10 Finland

Selective deficiency of immunoglobulin G [IgG] subclasses

7.7

7.9

R01

ICPC

Pain respiratory system

2.1

7.8

355

B01AC06

ATC

acetylsalicylic acid; oral

1.5

7.8

204

1339

R11

ICD-10 Finland

Nausea and vomiting

1.4

7.8

396

2946

C01AA05

ATC

digoxin; systemic

1.3

7.8

498

3837

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.4

7.8

394

2931

NXL00

NOMESCO Finland

Biopsy of muscle

3.4

7.8

JN5KR

NOMESCO Finland

Very extensive PET-CT of upper body metabolism (eyebrows to thighs)

3.6

7.7

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.6

7.7

175

1113

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

2.3

7.7

240

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

0.5

7.7

1491

WX213

NOMESCO Finland

Lower leg blockade

2.4

7.7

203

L17

ICPC

Foot/toe symptom/complaint

1.2

7.7

1547

13550

I84.1

ICD-10 Finland

Internal hemorrhoids with other complications

1.8

7.7

110

618

E84.1

ICD-10 Finland

Cystic fibrosis with intestinal manifestations

45.0

7.7

602

Kela drug reimbursment

Children's severe malnutrition

15.0

7.7

L40.0

ICD-10 Finland

Psoriasis vulgaris

1.6

7.7

184

1185

R78

ICPC

Acute bronchitis/bronchiolitis

1.8

7.7

100

546

B37.00

ICD-10 Finland

Acute pseudomembraneuous candidal stomatitis

3.9

7.7

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.2

7.7

1888

16825

EB1WA, ,

NOMESCO Finland

2.9

7.7

117

L01BB01, ,

ATC

5.9

7.7

R03BB05

ATC

aclidinium bromide; inhalant

3.4

7.7

SPAT1249

SPAT

Treatment-related counselling outside office

1.2

7.6

1881

16763

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

1.4

7.6

348

2545

F03

ICD-10 Finland

Unspecified dementia

0.6

7.6

110

1881

L04AA11

ATC

[U] etanercept

3.7

7.6

SPAT1254

SPAT

Administration of medicine

1.3

7.6

773

6323

D86.1

ICD-10 Finland

Sarcoidosis of lymph nodes

3.0

7.6

107

J70.1

ICD-10 Finland

Chronic and other pulmonary manifestations due to radiation

18.4

7.6

J70.3

ICD-10 Finland

Chronic drug-induced interstitial lung disorders

18.4

7.6

201

Kela drug reimbursment

Chronic cardiac insufficiency

1.4

7.6

339

2472

B48.5

ICD-10 Finland

Pneumocystosis

25.0

7.6

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.2

7.5

990

8326

L40.5

ICD-10 Finland

Arthropathic psoriasis

2.0

7.5

374

3A064, ,

NOMESCO Finland

3.1

7.5

8041/3-C34.3

ICD-O-3

Small cell carcinoma, NOS, of lower lobe, lung

8.8

7.5

R03AL11

ATC

formoterol, glycopyrronium bromide and budesonide; inhalant

2.3

7.5

224

WX204

NOMESCO Finland

Axillary plexus blockaced

1.6

7.5

150

925

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.2

7.5

1246

10724

R63.4

ICD-10 Finland

Abnormal weight loss

1.5

7.5

219

1475

TFC10

NOMESCO Finland

Catheterisation of left atrium or ventricle

1.9

7.5

508

GAC97

NOMESCO Finland

Other endoscopic operation on pleura

4.2

7.5

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

1.9

7.5

480

GD1AT

NOMESCO Finland

Biopsy of the lung with ultrasound guidance

3.0

7.4

103

P70

ICPC

Dementia

0.4

7.4

1005

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

2.0

7.4

390

NHM20

NOMESCO Finland

Excision of synovial ganglion of ankle or foot

2.4

7.4

207

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

1.7

7.4

126

746

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

7.4

151

938

A02BA04

ATC

nizatidine; systemic

1.4

7.4

383

2863

L02

ICPC

Back symptom/complaint

1.4

7.4

392

2941

M03BX02

ATC

tizanidine; oral

1.2

7.4

2801

25808

A01

ICPC

Pain general/multiple sites

1.3

7.3

491

3808

RT272, ,

NOMESCO Finland

4.0

7.3

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

1.7

7.3

123

725

M05.3

ICD-10 Finland

Rheumatoid arthritis with involvement of other organs and systems

8.4

7.3

FN1CD

NOMESCO Finland

Very extensive CT of coronary arteries

2.9

7.3

115

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.2

7.3

1091

9293

6BB16, ,

NOMESCO Finland

+∞

7.3

J98.6

ICD-10 Finland

Disorders of diaphragm

2.9

7.3

110

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.3

7.3

565

4473

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

1.8

7.2

112

645

L95.8

ICD-10 Finland

Other vasculitis limited to skin

3.8

7.2

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

1.8

7.2

108

616

GDB10

NOMESCO Finland

Wedge resection of lung

4.3

7.2

M01CC01

ATC

penicillamine; oral

5.8

7.2

M13.0

ICD-10 Finland

Polyarthritis, unspecified

2.2

7.2

267

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

1.8

7.2

107

610

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

2.1

7.2

287

3005

Kela drug reimbursment

Tofacitinib

4.5

7.2

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.2

7.2

878

7329

NK1XE

NOMESCO Finland

Other ultrasound examinnation of muscle or tendon

2.4

7.2

198

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

1.7

7.2

133

806

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

1.4

7.2

323

2360

NDG76

NOMESCO Finland

Fusion of DIP joint

2.5

7.1

168

J98.0

ICD-10 Finland

Diseases of bronchus, not elsewhere classified

3.1

7.1

I20.09

ICD-10 Finland

Unstable angina

1.4

7.1

335

2465

XX9XW, ,

NOMESCO Finland

2.8

7.1

117

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

1.7

7.1

119

702

7102A

ICD-9 Finland

Diffuse diseases of connective tissue, Sicca syndrome[SYNDROMA SICCUM PRIMARIUM]

12.0

7.1

4130B

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),AHTAUTUNUT]

1.8

7.1

101

569

XG480

NOMESCO Finland

Histamine provocation of respiratroy tract

2.2

7.0

250

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

2.1

7.0

276

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.5

7.0

213

1446

D80.8

ICD-10 Finland

Other immunodeficiencies with predominantly antibody defects

10.0

7.0

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.3

7.0

475

3692

D07BC01

ATC

betamethasone and antiseptics; topical

1.3

7.0

555

4405

L01

ICPC

Neck symptom/complaint

1.3

7.0

668

5424

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.3

7.0

639

5164

R13

ICD-10 Finland

Dysphagia

1.4

6.9

369

2769

M81.8

ICD-10 Finland

Other osteoporosis

2.2

6.9

239

J15.1

ICD-10 Finland

Pneumonia due to Pseudomonas

6.3

6.9

NG1EA

NOMESCO Finland

Knee X-ray examination with wrench

2.0

6.9

359

NDB78

NOMESCO Finland

Prosthetic replacement of several of finger or metacarpal

5.8

6.9

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.2

6.9

1506

13268

M01AE03

ATC

ketoprofen; systemic, rectal

1.2

6.9

1845

16525

RK310, ,

NOMESCO Finland

7.5

6.9

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

1.6

6.9

149

939

SPAT1097

SPAT

Recording of ECG

1.2

6.9

777

6430

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

2.4

6.9

196

Z50.1

ICD-10 Finland

Other physical therapy

1.4

6.8

250

1760

R06AX22

ATC

ebastine; oral

1.3

6.8

628

5076

K76.9

ICD-10 Finland

Liver disease, unspecified

2.1

6.8

300

I25

ICD-10 Finland

Chronic ischaemic heart disease

1.4

6.8

285

2057

C10AC01

ATC

colestyramine; oral

1.7

6.8

120

718

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

2.0

6.8

334

5010A

ICD-9 Finland

Asbestosis[ASBESTOSIS]

9.3

6.8

G73.7*M35.0

ICD-10 Finland

Myopathy in sicca syndrome [Sjögren]

9.3

6.8

D72.8

ICD-10 Finland

Other specified disorders of white blood cells

2.4

6.8

191

Z01.2

ICD-10 Finland

Dental examination

1.2

6.8

1987

17920

4038, ,

NOMESCO Finland

40.1

6.8

XV5WT, ,

NOMESCO Finland

40.1

6.8

WNF00

NOMESCO Finland

Infection source and contact determination

3.1

6.7

R07.3

ICD-10 Finland

Other chest pain

1.3

6.7

493

3873

WX730

NOMESCO Finland

Conventional respirator

1.9

6.7

426

UDM02

NOMESCO Finland

Sinoscopy

1.8

6.7

505

R053, ,

ICD-10 Finland

1.7

6.7

126

767

RK520, ,

NOMESCO Finland

3.2

6.7

NB2AT

NOMESCO Finland

Intra artrial injection of shoulder with ultrasound guidance

2.1

6.7

269

K08.3

ICD-10 Finland

Retained dental root

1.3

6.7

387

2943

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

1.6

6.7

133

822

EB1CI

NOMESCO Finland

Cone beam imaging of teeth and jaws (3-4 quarters)

2.2

6.6

237

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

1.6

6.6

161

1043

SPAT1281

SPAT

Other administrative function

1.4

6.6

348

2607

X58

ICD-10 Finland

Exposure to other specified factors

1.3

6.6

600

4843

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

0.4

6.6

732

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.5

6.6

199

1351

H15.0

ICD-10 Finland

Scleritis

3.6

6.6

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

2.0

6.6

311

WPA44

NOMESCO Finland

Nursing home for palliative care

3.3

6.5

M10.0

ICD-10 Finland

Idiopathic gout

1.5

6.5

207

1419

TEA00

NOMESCO Finland

Biopsy of lip

2.2

6.5

239

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

6.5

1878

16903

ZX140

NOMESCO Finland

Intra articular

2.4

6.5

164

KMAK, ,

NOMESCO Finland

1.2

6.4

2167

19721

M05BX03

ATC

strontium ranelate; oral

2.6

6.4

135

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.4

6.4

294

2154

J99.1*M33.9

ICD-10 Finland

Respiratory disorders in dermatopolymyositis

69.9

6.4

51701

ICD-8 Finland

Other chronic interstitial pneumonia, Fibrosis interstitialis diffusa pulmonum essentialis (Hamman-Rich)

69.9

6.4

ZXX03

NOMESCO Finland

Extent of procedure, 3 units

2.8

6.4

107

N30.2

ICD-10 Finland

Other chronic cystitis

2.2

6.4

215

M06.4

ICD-10 Finland

Inflammatory polyarthropathy

3.3

6.4

N08.5*M31.7

ICD-10 Finland

Glomerular disease states in microscopic polyangiitis

7.4

6.4

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

1.4

6.4

226

1583

R42

ICD-10 Finland

Dizziness and giddiness

1.2

6.4

1230

10713

K59.1

ICD-10 Finland

Functional diarrhoea

1.4

6.4

254

1819

WW409

NOMESCO Finland

Other aferesis

4.1

6.3

S22.3

ICD-10 Finland

Fracture of rib

1.3

6.3

358

2712

XG467

NOMESCO Finland

Nocturnal CO2 monitoring

6.5

6.3

J92

ICD-10 Finland

Pleural plaque

6.5

6.3

J01DA06

ATC

[U] cefuroxime

1.3

6.3

599

4860

C83.80

ICD-10 Finland

B-cell lymphoma in marginal zone

3.1

6.3

E66.8

ICD-10 Finland

Other obesity

1.5

6.3

172

1144

103

Kela drug reimbursment

Diabetes, insulin-treated

1.2

6.3

1515

13438

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.7

6.3

114

688

XG430

NOMESCO Finland

Spiroegometry

9.2

6.3

SPAT1058

SPAT

PEF monitoring instruction

1.3

6.3

362

2751

Z01.9

ICD-10 Finland

Special examination, unspecified

1.4

6.3

280

2044

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

2.1

6.3

276

-44

ICPC

Preventive immunization/medic

1.3

6.3

417

3234

S01BA01

ATC

dexamethasone; ophthalmic

1.6

6.3

150

969

XG413

NOMESCO Finland

Spirometry with oscillometry

18.0

6.3

D84.8

ICD-10 Finland

Other specified immunodeficiencies

26.7

6.2

R03AC18

ATC

indacaterol; inhalant

2.3

6.2

205

M60.9

ICD-10 Finland

Myositis, unspecified

2.6

6.2

126

M70.2

ICD-10 Finland

Olecranon bursitis

1.5

6.2

173

1156

E000007, ,

ATC

1.5

6.2

192

1311

C61

ICD-10 Finland

Malignant neoplasm of prostate

0.8

6.2

421

5358

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

1.7

6.2

109

653

I20.91

ICD-10 Finland

Angina pectoris, unspecified

1.8

6.2

431

D07AA02

ATC

hydrocortisone; topical

1.3

6.2

555

4474

D01

ICPC

Abdominal pain/cramps general

1.3

6.2

485

3846

A07EA06

ATC

budesonide; oral, local oral

1.6

6.1

142

910

I71.4

ICD-10 Finland

Abdominal aortic aneurysm, without mention of rupture

1.6

6.1

145

934

J15

ICD-10 Finland

Bacterial pneumonia, not elsewhere classified

5.7

6.1

D68.8

ICD-10 Finland

Other specified coagulation defects

2.3

6.1

200

R03BC03

ATC

nedocromil; inhalant

1.4

6.1

277

2029

A91

ICPC

Abnormal result investigation NOS

1.4

6.1

257

1859

N02BF01

ATC

gabapentin; oral

1.3

6.1

463

3656

N05AX08

ATC

risperidone; systemic

0.7

6.1

243

3343

M34

ICD-10 Finland

Systemic sclerosis

12.5

6.1

M05BA01

ATC

etidronic acid; systemic

2.7

6.1

116

M00.9

ICD-10 Finland

Pyogenic arthritis, unspecified

2.0

6.1

300

SFA20

NOMESCO Finland

Two-surface restoration

1.1

6.1

2554

23584

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.2

6.0

1127

9783

GX1P5

NOMESCO Finland

Nocturnal CO2 monitoring

8.6

6.0

N02BF02

ATC

pregabalin; oral

1.4

6.0

287

2117

L95.9

ICD-10 Finland

Vasculitis limited to skin, unspecified

2.8

6.0

105

M87.0

ICD-10 Finland

Idiopathic aseptic necrosis of bone

2.4

6.0

170

TKC20

NOMESCO Finland

Catheterisation of bladder

1.3

6.0

377

2899

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

1.8

6.0

478

R5599

NOMESCO Finland

Other rehabilitation service

1.6

6.0

121

750

UJD02

NOMESCO Finland

Gastroscopy

1.4

6.0

230

1635

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1866

7707

3.07

320.06

9.6

7.4

5.02

5.08

kpa

1.80

1810

7400

(3027801) Oxygen [Partial pressure] in Arterial blood

1865

7704

3.07

319.77

9.6

7.4

10.41

12.08

kpa

49.62

1812

7395

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

541

891

6.58

317.50

1.4

1.2

59.06

45.23

u/ml

0.80

(3019977) pH of Arterial blood

1847

7683

3.04

311.63

9.7

7.4

7.43

7.42

6.51

1163

4231

(3003396) Base excess in Arterial blood by calculation

1839

7641

3.04

310.80

9.6

7.3

1.30

0.96

mmol/l

2.88

1590

6240

(3002030) Lymphocytes/Leukocytes in Blood

4466

25365

4.04

307.65

14.1

6.3

24.71

26.16

15.38

4407

23843

(3013650) Neutrophils [#/volume] in Blood by Automated count

4766

30367

3.85

307.65

17.0

9.4

4.68

4.29

e9/l

23.27

4361

26061

(44806118) Parainfluenza type 4 nucleic acid detection

541

666

8.83

307.65

2.6

1.3

—

(3023419) Bacteria identified in Sputum by Culture

693

761

10.17

307.65

2.7

2.5

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

582

744

8.56

307.65

1.2

1.1

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

1345

4029

4.02

307.65

2.1

1.4

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

300

121

26.06

307.65

1.1

—

(3005719) IgG [Mass/volume] in Serum or Plasma

1484

3939

4.69

307.65

4.3

2.7

10.47

10.58

g/l

0.35

1428

3613

(3006184) Hemoglobin [Mass/volume] in Capillary blood

746

1520

5.47

307.65

2.6

2.3

128.73

127.24

g/l

0.56

350

1219

(3018010) Neutrophils/Leukocytes in Blood

4425

24862

4.04

307.65

13.5

6.2

60.29

58.42

20.74

4378

23571

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1610

2305

9.20

307.65

1.6

18.25

15.32

iu/ml

0.16

(3037522) Nuclear Ab [Titer] in Serum

2689

6316

6.94

307.65

1.6

1.3

559.61

498.06

titre

0.94

815

1380

(3037692) Legionella sp identified in Specimen by Organism specific culture

339

164

21.86

307.65

1.9

1.3

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

662

879

8.35

307.65

1.5

1.3

15.74

8.38

u/ml

0.79

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

806

1024

8.95

307.65

1.3

1.2

14.95

2.13

u/ml

1.65

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

646

1042

6.83

307.65

1.3

192.50

128.42

titre

0.24

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1030

1445

8.41

307.65

2.4

1.5

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2354

7733

4.38

307.65

1.4

1.3

25.74

12.40

u/ml

2.96

703

2803

(42529582) MDA5 Ab [Presence] in Serum by Line blot

300

121

26.06

307.65

1.1

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2111

8196

3.44

307.65

2.7

1.8

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

462

621

7.98

307.65

3.4

3.7

—

(3006315) Basophils [#/volume] in Blood

4725

27053

4.61

307.65

13.3

6.0

0.04

e9/l

4.54

4291

22795

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1055

1662

7.50

307.65

1.3

1.2

1.93

1.04

u/ml

0.80

145

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

743

1435

5.77

307.65

1.9

1.5

1.20

1.18

g/l

0.76

723

1363

(44790047) Parainfluenza type 1 nucleic acid detection

541

666

8.83

307.65

2.6

1.3

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

874

360

28.28

307.65

2.1

1.4

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2510

10933

3.24

307.65

2.9

1.9

—

(3042631) Mycobacterium sp identified in Specimen

624

838

8.20

307.65

3.0

2.7

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

472

629

8.06

307.65

1.2

1.1

34.00

7.75

u/ml

1.55

(3028026) IgM [Mass/volume] in Serum or Plasma

1150

3125

4.32

307.65

2.2

1.9

1.09

1.39

g/l

5.48

1081

2822

(44790049) Parainfluenza type 3 nucleic acid detection

541

666

8.83

307.65

2.6

1.3

—

(3001604) Monocytes [#/volume] in Blood

4720

26943

4.63

307.65

13.3

6.0

0.67

0.62

e9/l

22.15

4284

22676

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2024

7614

3.51

307.65

2.7

1.9

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

607

733

9.11

307.65

2.3

1.5

—

(3006504) Eosinophils/Leukocytes in Blood

4457

24984

4.12

307.65

13.9

6.3

2.72

2.85

3.80

4393

23213

(3005322) IgE [Units/volume] in Serum or Plasma

1001

2745

4.18

307.65

1.6

1.3

249.44

244.55

u/ml

0.05

943

2515

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

738

1388

5.93

307.65

1.9

1.5

0.23

0.24

g/l

2.95

715

1321

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1039

1468

8.36

307.65

2.3

1.5

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1043

1195

10.37

307.65

2.1

1.4

—

(44790048) Parainfluenza type 2 nucleic acid detection

541

666

8.83

307.65

2.6

1.3

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

850

1204

8.07

307.65

1.4

1.2

7.02

5.39

u/ml

0.16

107

109

(3023420) DNA double strand Ab [Units/volume] in Serum

1168

1827

7.71

307.65

2.1

1.6

7.20

6.63

iu/ml

0.24

269

434

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1263

1957

7.92

307.65

1.4

1.2

—

(3019198) Lymphocytes [#/volume] in Blood

4733

27488

4.52

307.65

13.5

6.1

1.91

1.86

e9/l

0.66

4350

23705

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

750

1027

8.21

307.65

2.4

1.6

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1190

1317

11.04

307.65

1.9

1.5

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

637

210

33.85

307.65

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

300

121

26.06

307.65

1.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

842

1207

7.96

307.65

1.4

1.3

12.53

5.54

u/ml

1.70

162

183

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

709

865

9.17

307.65

1.8

1.4

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1217

1079

13.92

307.65

1.3

1.2

49.66

0.60

u/ml

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

300

121

26.06

307.65

1.1

—

(3022096) Basophils/Leukocytes in Blood

4445

24982

4.07

307.65

14.1

6.4

0.64

0.66

1.86

4382

23206

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2479

8318

4.39

307.65

1.4

1.3

58.28

35.21

iu/ml

5.07

839

2455

(3013115) Eosinophils [#/volume] in Blood

4771

27811

4.60

307.65

14.0

6.2

0.21

0.20

e9/l

3.27

4389

23795

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

653

738

9.81

307.65

2.6

1.4

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

649

1067

6.70

307.65

12.5

4.5

1342.73

1844.19

iu/ml

0.11

154

149

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

977

2149

5.24

307.65

1.8

38.88

38.53

u/l

0.18

897

1854

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

946

1033

10.70

307.65

2.1

1.4

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

646

1044

6.82

307.65

1.3

1.2

266.81

316.09

titre

0.24

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

770

1042

8.34

307.65

1.8

1.4

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1466

2238

8.36

307.65

3.1

2.6

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

996

1546

7.54

307.65

1.8

1.4

14.59

16.57

iu/ml

0.14

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

863

1273

7.76

307.65

1.4

1.2

43.77

44.84

u/ml

0.03

(3019069) Monocytes/Leukocytes in Blood

4461

25047

4.11

307.65

14.1

6.4

9.00

9.16

3.19

4395

23271

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

496

492

10.91

307.65

1.2

1.1

56.54

37.11

u/ml

0.55

(3039162) Centromere protein B Ab [Units/volume] in Serum

406

516

8.37

300.77

1.4

1.2

61.02

54.33

u/ml

0.14

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

632

1323

5.23

286.91

1.8

1.9

11.71

12.81

mg/l

1.24

599

1217

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

347

384

9.53

286.73

2.0

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

326

335

10.24

284.52

2.0

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

329

348

9.95

281.12

2.0

1.5

—

(3000494) Fungus identified in Specimen by Culture

1576

6368

3.01

275.72

2.3

1.4

—

(3023368) Bacteria identified in Blood by Culture

3135

17928

2.58

275.17

6.2

4.5

—

(3004616) Nuclear Ab [Presence] in Serum

401

579

7.35

265.59

1.4

1.2

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1452

5815

2.98

256.00

1.6

—

(3017181) Myelocytes/Leukocytes in Blood

1343

5162

3.07

254.65

7.1

4.2

0.85

1.00

1.61

564

1681

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

4339

29701

2.70

250.29

11.0

6.7

11.30

12.52

umol/l

7.87

4246

28340

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

152

38.02

246.63

3.0

1.7

—

(3002179) Metamyelocytes/Leukocytes in Blood

1283

4902

3.06

244.96

6.8

4.1

0.59

0.75

1.87

527

1584

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

333

426

8.22

244.80

1.3

1.1

79.40

78.44

u/ml

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

3318

20218

2.45

243.36

4.4

3.4

1685.88

1724.14

ng/l

0.16

3025

17750

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

348

483

7.59

238.47

2.1

1.5

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

340

465

7.69

235.99

1.4

1.3

7.52

6.73

g/l

1.82

239

332

(3028192) IgG subclass 2 [Mass/volume] in Serum

339

465

7.67

234.68

1.4

1.3

3.01

2.94

g/l

0.24

240

335

(3024139) IgG subclass 3 [Mass/volume] in Serum

339

465

7.67

234.68

1.4

1.3

0.50

0.41

g/l

2.28

237

335

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

451

851

5.65

228.74

5.5

2.3

649.41

2341.23

u/ml

1.07

(4062490) Immunoglobulin typing, IgG

331

458

7.59

227.32

1.4

1.3

—

(3016502) Oxygen saturation in Arterial blood

1572

6964

2.71

225.58

10.4

7.6

93.94

95.39

14.41

1526

6718

(3021440) Promyelocytes/Leukocytes in Blood

1251

4933

2.94

223.89

7.2

4.2

0.07

0.12

2.51

467

1460

(3024980) IgG subclass 4 [Mass/volume] in Serum

430

799

5.72

221.61

1.8

1.6

0.89

0.87

g/l

0.11

314

622

(3025159) Blasts/Leukocytes in Blood

1242

4933

2.92

218.92

7.4

4.4

0.21

0.24

0.05

452

1371

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3956

26801

2.42

218.08

10.7

6.9

1.20

1.21

mmol/l

4.51

3793

24659

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1069

3933

3.09

215.84

11.5

9.2

24.68

24.24

mmol/l

3.79

1040

3837

(3018418) pH of Serum or Plasma

2972

17968

2.31

211.91

6.1

4.4

7.40

2.02

2239

13061

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

289

379

7.96

207.75

1.3

1.1

—

(3042936) Bacteria identified in Isolate by Culture

1736

8413

2.50

204.01

2.6

2.0

—

(3021589) Normoblasts [#/volume] in Blood

3512

23082

2.27

200.59

22.9

12.5

0.00

e9/l

0.92

2968

18670

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

4989

38337

2.86

198.96

10.7

4.5

18.19

13.86

mm/h

57.49

4898

35479

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

263

335

8.17

193.67

1.3

1.1

—

(3038026) Centromere Ab [Units/volume] in Serum

272

367

7.72

190.68

1.3

1.2

40.27

73.61

u/ml

0.75

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

4177

29887

2.33

188.93

11.8

7.7

1.21

mmol/l

2.92

3667

25750

(40760892) CBC W Ordered Manual Differential panel - Blood

2003

10705

2.31

185.69

10.1

4.8

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

249

313

8.26

185.33

4.0

3.7

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

324

547

6.21

184.05

2.0

1.6

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

198

187

10.92

182.84

2.1

1.9

46334.29

19548.50

u/ml

0.25

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

331

579

5.99

181.31

2.0

1.6

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1764

9080

2.34

177.16

2.0

1.5

2.82

2.63

g/l

2.76

1287

5280

(40759836) Histone Ab [Presence] in Serum by Immunoblot

242

329

7.62

168.40

1.3

1.1

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1131

4845

2.65

168.38

2.2

2.4

345.31

382.85

nmol/l

5.83

1079

4467

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

795

2837

3.08

166.66

2.4

1.9

1.78

2.42

ug/l

0.55

727

2481

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

235

315

7.73

165.53

1.3

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

237

323

7.60

164.54

1.3

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

237

323

7.60

164.54

1.3

1.1

—

(3018333) Ribosomal P Ab [Presence] in Serum

229

301

7.87

164.04

1.3

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

231

308

7.76

163.45

1.3

1.1

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1044

4364

2.69

162.82

6.1

3.9

5.15

kpa

0.09

1009

4155

(3009343) pH of Capillary blood

1022

4242

2.70

161.54

6.1

3.9

7.42

5.40

895

3517

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2016

11375

2.17

158.64

2.5

1.7

1.52

1.48

mg/l

0.15

1699

8952

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

523

1479

3.78

158.49

1.6

1.5

55.73

5.29

iu/ml

0.90

110

304

(3021879) Hepatitis B virus core Ab [Presence] in Serum

808

2994

2.97

158.03

1.4

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1338

6401

2.41

156.25

11.7

8.1

123.62

120.05

g/l

7.43

1313

6258

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

390

898

4.58

155.94

1.4

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

387

894

4.56

154.08

1.4

39.23

17.53

u/ml

—

(3035933) Granulocytes/Leukocytes in Blood

425

1059

4.24

153.45

4.5

3.4

59.52

58.28

0.97

425

1059

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

355

776

4.80

151.26

1.4

154.59

156.13

au/ml

0.07

232

(3042733) HLA Ab [Presence] in Serum

143

109

13.42

151.21

4.4

4.7

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1048

4541

2.59

151.06

1.6

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

915

3720

2.72

149.87

5.7

3.8

2.29

1.87

mmol/l

2.63

722

2718

(3011412) CD3 cells [#/volume] in Blood

268

465

5.99

147.77

2.2

2.1

1015.98

1121.31

e6/l

1.05

241

411

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

178

197

9.28

146.44

1.2

1.1

—

(36304419) Bacteria [Presence] in Urine

2514

15881

2.01

142.05

5.0

3.5

0.61

168.89

estimate

—

(1175426) CD3 cells/Lymphocytes in Blood

231

362

6.60

140.94

2.1

2.0

72.99

71.20

0.73

223

338

(3015235) Bicarbonate [Moles/volume] in Capillary blood

669

2374

3.05

140.55

4.7

3.0

25.25

24.77

mmol/l

2.22

652

2338

(1616796) Gas panel - Central venous blood

487

1422

3.64

140.35

5.5

4.0

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1137

5282

2.42

140.25

1.6

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

5047

41171

2.48

139.32

16.7

8.6

79.48

81.92

u/l

2.76

4969

38958

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2629

16985

1.98

138.16

5.4

3.2

34.25

36.89

u/l

0.78

2524

15911

(3024561) Albumin [Mass/volume] in Serum or Plasma

3662

26513

1.99

137.64

6.9

5.2

33.66

34.84

g/l

29.44

3465

24727

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

220

342

6.64

135.24

2.1

1.9

16.01

16.09

0.03

215

329

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

222

349

6.57

135.00

2.2

1.9

—

(3021901) Oxygen saturation in Capillary blood

479

1423

3.57

134.36

4.6

3.0

88.80

89.08

0.36

468

1388

(40767503) Oxygen content in Capillary blood by calculation

455

1336

3.60

129.81

3.7

2.7

15.87

16.03

0.45

446

1310

(3030467) Casts [#/volume] in Urine by Automated count

2590

16924

1.94

129.02

5.1

3.6

0.40

0.47

e6/l

0.77

2019

12739

(3028626) Oxygen [Partial pressure] in Capillary blood

522

1683

3.30

128.58

5.6

3.4

7.74

7.97

kpa

2.61

509

1648

(3018095) Leukocytes [#/volume] in Urine

3092

21442

1.92

128.46

6.5

4.3

97.10

109.72

e6/l

0.26

2368

15697

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

936

4129

2.50

128.36

13.0

7.8

25.01

24.81

mmol/l

0.81

927

4103

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

254

479

5.49

128.06

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

254

479

5.49

128.06

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

254

479

5.49

128.06

1.6

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

183

251

7.49

126.18

1.4

1.2

—

(3002582) Erythrocytes [#/volume] in Urine

2871

19607

1.90

123.20

5.3

3.7

91.39

93.23

e6/l

0.01

2311

15272

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

243

456

5.51

123.15

1.4

1.2

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1755

10157

2.03

123.07

6.8

3.2

0.81

mmol/l

1.87

1658

9508

(3032080) INR in Blood by Coagulation assay

3819

28663

1.93

121.69

19.2

19.1

1.31

1.34

inr

3.04

3314

24211

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

3062

21452

1.88

120.31

5.3

3.7

—

1.49

—

(3024932) HLA-DR beta [Type]

123

110

11.40

117.64

1.0

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

246

493

5.16

115.80

1.4

1.2

—

(3024471) HLA-A [Type]

123

113

11.09

115.54

1.0

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1811

10813

1.97

114.74

3.1

2.8

11.63

12.25

umol/l

3.45

1712

10017

(3008152) Bicarbonate [Moles/volume] in Arterial blood

903

4125

2.40

113.75

8.0

6.6

24.91

24.49

mmol/l

2.52

878

3951

(3017732) Neutrophils [#/volume] in Blood

1250

6553

2.15

112.98

4.0

3.4

4.63

4.79

e9/l

0.36

1137

5468

(3026782) Osmolality of Urine

1922

11759

1.94

112.97

4.1

3.1

522.33

536.29

mosm/kgh2o

2.53

1752

10328

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

472

1552

3.22

112.18

3.5

2.3

3.81

3.60

g/l

2.14

464

1475

(3001964) Herpes simplex virus Ag [Presence] in Specimen

128

131

9.96

111.52

3.0

1.3

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

4243

33437

1.94

111.04

9.4

5.3

6.83

6.85

mmol/l

0.33

4121

31928

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1715

10185

1.96

109.45

3.0

2.7

2.23

2.26

g/l

0.84

1602

9368

(3020779) Urea [Moles/volume] in Serum or Plasma

1176

6098

2.16

108.89

11.7

7.0

10.74

11.04

mmol/l

0.69

1132

5808

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1623

9487

1.98

108.29

3.1

2.8

20.96

21.83

1.79

1533

8778

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

152

202

7.70

107.69

3.5

1.8

41.73

59.46

ug/l

2.19

152

194

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

274

638

4.45

107.57

1.4

1.2

4.40

3.44

u/ml

0.27

126

204

(40758558) Short blood count panel - Blood

2422

16220

1.83

105.50

10.4

6.4

—

(3033099) Centromere Ab [Titer] in Serum

109

11.55

105.27

1.2

1.1

—

(3000850) Epithelial cells [#/volume] in Urine

2149

13883

1.86

105.06

3.9

2.9

4.75

4.61

e6/l

0.15

1994

12655

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1068

5445

2.17

102.68

4.4

3.1

226.87

232.70

ng/l

0.16

1004

5027

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

293

760

4.00

99.62

1.2

349.80

287.88

u/ml

1.51

188

447

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1372

7769

2.00

99.02

5.0

4.3

264.41

245.36

u/l

4.19

1315

7348

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

878

4201

2.28

98.37

2.1

1.8

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

261

629

4.29

97.95

1.3

1.2

5.40

4.46

u/ml

0.28

161

275

(3000991) Gas panel - Venous blood

1081

5641

2.12

97.40

13.5

8.6

—

(3009871) Measles virus Ab [Titer] in Serum

115

123

9.51

96.97

1.4

1.6

2384.00

3810.91

titre

—

(3010375) cycloSPORINE [Mass/volume] in Blood

141

194

7.42

96.89

46.6

25.6

156.52

106.57

ug/l

8.31

110

159

(3010503) CD19 cells [#/volume] in Blood

176

309

5.84

95.67

2.2

2.1

102.58

120.14

e6/l

0.47

171

295

(3020630) Protein [Mass/volume] in Serum or Plasma

1108

5873

2.09

95.61

2.4

2.6

66.21

65.92

g/l

0.56

1037

5324

(3027315) Oxygen [Partial pressure] in Blood

392

1276

3.22

94.41

6.7

4.5

8.25

8.43

kpa

1.16

385

1249

(3026250) Tacrolimus [Mass/volume] in Blood

132

174

7.74

94.15

48.0

36.1

7.97

7.28

ug/l

2.12

120

153

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

197

392

5.16

93.40

2.3

2.4

43.38

26.67

iu/ml

0.51

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

805

3793

2.30

93.22

14.7

9.7

16.05

15.85

1.16

779

3667

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2641

18622

1.75

92.99

3.6

2.2

145.92

225.24

u/l

8.24

2520

17518

(3037467) Urinalysis macro (dipstick) panel - Urine

4444

36401

1.87

92.55

7.4

4.9

1.68

2.17

—

(3012501) Base excess in Blood by calculation

387

1268

3.19

92.16

6.7

4.4

2.69

2.65

mmol/l

0.09

294

866

(3013290) Carbon dioxide [Partial pressure] in Blood

387

1269

3.19

92.04

6.7

4.4

5.00

kpa

0.04

380

1243

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

15.69

91.46

1.6

1.5

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

239

568

4.34

91.30

1.3

1.1

118.29

113.84

1.07

229

503

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

427

1490

3.01

91.23

3.7

2.2

90.59

89.69

0.37

418

1441

(40757373) Influenza virus identified in Isolate

105

108

9.88

91.11

2.9

1.4

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

175

320

5.60

91.10

1.5

1.3

0.86

2.37

u/ml

1.58

115

187

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1413

8293

1.92

90.72

8.3

6.1

1.05

1.04

mmol/l

0.79

1335

7688

(4195642) Thrombophilia screening test

236

560

4.35

90.33

1.3

1.2

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

405

1379

3.08

90.31

3.9

2.4

213.69

207.03

0.70

388

1317

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1856

11891

1.81

90.17

5.3

4.3

444.93

482.50

ng/l

0.15

1655

10188

(21494814) CD8 cells/Lymphocytes in Specimen

136

195

7.11

90.05

2.0

30.50

31.66

0.29

136

195

(3010421) pH of Blood

510

1978

2.73

89.52

6.0

3.9

7.42

7.41

2.06

503

1955

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

125

164

7.76

89.51

2.1

1.9

1.91

1.71

ratio

0.43

117

155

(3014111) Lactate [Moles/volume] in Serum or Plasma

1083

5858

2.04

87.71

12.1

7.3

1.43

1.36

mmol/l

0.98

1060

5737

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

472

1784

2.79

87.01

1.7

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

2758

19997

1.71

85.35

4.5

3.6

2.34

2.35

mmol/l

2.76

2574

17976

(3021601) Nitrite [Presence] in Urine by Test strip

3595

28011

1.72

84.95

5.6

4.2

0.00

estimate

1.08

1015

6003

(4268621) Lupus anticoagulant assay

199

436

4.69

84.19

2.4

2.3

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

340

1090

3.25

83.83

1.3

1.2

—

(3026493) Urate [Moles/volume] in Serum or Plasma

2197

15026

1.73

83.74

5.1

3.0

360.23

358.06

umol/l

0.41

1975

13004

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

896

4599

2.12

83.22

1.9

1.7

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

200

445

4.62

83.02

1.2

96.57

94.79

0.37

194

414

(3017569) Oxygen content in Arterial blood

190

406

4.80

82.85

2.3

2.1

16.64

16.01

1.53

190

406

(3035350) Ketones [Presence] in Urine by Test strip

3618

28359

1.70

82.42

5.6

4.2

3.65

4.40

estimate

0.13

1035

6198

(3009261) Glucose [Presence] in Urine by Test strip

3635

28548

1.70

82.01

5.6

4.3

0.01

0.24

estimate

0.70

983

5754

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3157

23896

1.68

81.79

3.2

2.4

77.69

79.21

nmol/l

2.45

2938

21142

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

232

595

4.02

80.01

1.2

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

192

429

4.59

79.28

1.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

161

310

5.31

79.19

2.2

201.01

233.14

e6/l

0.98

137

269

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

162

314

5.28

79.10

2.0

2.1

457.92

519.51

e6/l

0.63

124

255

(3033658) Prothrombin time (PT) actual/Normal

2076

14151

1.72

78.94

6.9

4.4

84.71

84.73

0.01

2042

13855

(3028271) Lactate [Moles/volume] in Capillary blood

308

969

3.30

78.26

2.3

1.9

1.66

1.70

mmol/l

0.32

302

941

(3027945) Reticulocytes/Erythrocytes in Blood

1343

8096

1.85

77.69

3.7

2.5

1.94

1.77

6.81

1207

7182

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

153

289

5.41

76.87

2.1

1.5

5.97

6.62

u/l

0.41

139

246

(3036489) Thrombin time

476

1924

2.60

76.61

3.5

1.9

21.46

21.41

0.05

441

1740

(3022313) Gas panel - Capillary blood

636

2955

2.29

75.30

6.6

4.2

—

(3031040) Bacteria [#/volume] in Urine by Automated count

4300

35741

1.73

74.76

6.9

5.3

638.81

1925.42

e6/l

2.27

587

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

151

290

5.32

74.48

1.2

89.50

80.33

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1155

6741

1.89

73.51

5.0

3.8

5.86

5.81

kpa

0.76

1126

6566

(3002032) Base excess in Venous blood by calculation

1129

6563

1.89

72.66

5.0

3.8

2.13

1.77

mmol/l

2.26

997

5700

(3008536) Aspergillus sp Ab [Presence] in Serum

116

8.31

72.23

1.6

1.8

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3225

25050

1.63

71.29

3.1

2.5

—

(3012544) pH of Venous blood

1161

6849

1.86

71.20

5.0

3.8

7.38

1.20

674

4035

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

146

288

5.17

69.89

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

146

288

5.17

69.89

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

146

288

5.17

69.89

1.7

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

172

390

4.51

69.72

1.3

1.2

112.73

123.85

titre

0.12

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

172

390

4.51

69.72

1.3

1.2

165.26

126.03

titre

0.33

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1515

9737

1.75

69.48

4.6

3.4

1.74

1.95

e6/l

0.49

783

5027

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

123

208

6.02

69.48

1.7

1.9

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

123

208

6.02

69.48

1.7

1.9

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1025

5855

1.91

69.30

2.3

2.2

0.21

0.20

g/l

2.28

948

5447

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

123

209

5.99

69.14

1.7

1.9

—

(3014007) Fractional oxyhemoglobin in Arterial blood

819

4342

2.03

68.78

15.1

9.2

92.61

93.91

7.38

813

4327

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

344

1244

2.87

68.59

1.5

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

344

1244

2.87

68.59

1.5

1.3

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

144

288

5.10

67.85

1.7

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1493

9631

1.73

67.23

2.9

2.0

29.86

29.94

0.19

1458

9361

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2240

16151

1.62

65.33

2.7

2.4

3.03

2.91

mg/l

1.62

1993

13865

(3023520) Reticulocytes [#/volume] in Blood

1079

6391

1.84

64.67

3.5

2.5

72.25

67.65

e9/l

3.14

738

4743

(3028433) Virus identified in Specimen by Culture

104

161

6.56

64.11

1.1

1.2

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

785

4201

2.00

63.91

15.5

9.4

0.60

0.63

1.05

779

4171

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

731

3825

2.04

63.34

5.1

3.9

24.35

24.12

mmol/l

1.13

725

3778

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

801

4344

1.98

62.70

15.3

9.1

1.33

1.28

0.83

795

4317

(3015736) pH of Urine

2912

22547

1.57

61.50

4.5

3.7

6.21

6.26

1.61

1429

12320

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

9.58

61.27

1.2

46.11

44.45

mg/l

0.07

(3034860) Kappa light chains.free [Mass/volume] in Serum

529

2490

2.23

60.20

2.9

3.4

56.76

82.08

mg/l

0.60

409

2148

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

528

2485

2.23

60.10

2.9

3.4

43.51

55.99

mg/l

1.04

407

2140

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

856

4822

1.91

59.65

5.0

4.2

1.22

1.23

mmol/l

2.61

782

4176

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2983

23353

1.56

59.06

3.8

3.2

193.51

153.18

ug/l

7.17

2768

21433

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

9.10

58.96

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

108

7.68

58.52

1.1

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

4530

39108

1.66

58.36

43.2

24.0

14.30

13.86

71.69

4517

38562

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1571

10627

1.65

57.70

4.3

3.3

0.91

1.12

e6/l

1.64

855

5928

(3034426) Prothrombin time (PT)

129

6.91

57.10

1.1

1.3

26.92

28.80

2.41

129

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

9.95

56.89

1.1

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

634

3275

2.05

56.60

1.6

1.5

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

133

291

4.65

56.36

2.5

2.6

38.27

37.85

0.08

162

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

480

2232

2.25

56.15

2.9

3.3

1.78

5.40

ratio

1.66

226

1335

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2907

22807

1.54

55.73

5.5

4.4

41.00

88.38

ng/l

1.71

2380

17831

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

164

6.00

54.82

2.0

1.9

30.74

29.67

0.23

151

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

588

3022

2.05

53.09

5.4

5.0

1.72

1.57

3.80

563

2863

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

171

475

3.68

52.61

1.1

1.67

2.62

iu/ml

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

487

2341

2.18

52.39

3.9

2.9

0.32

0.34

iu/ml

0.87

275

1282

(40761536) Microorganisms panel - Urine sediment

753

4234

1.89

52.32

5.8

4.3

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

314

1244

2.61

52.31

1.3

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

288

1093

2.72

52.26

1.3

—

(3006245) CD3-CD19+ cells/cells in Blood

163

5.84

51.77

2.1

1.9

8.71

11.87

1.28

145

(3046861) Legionella sp Ag [Presence] in Urine

13.93

51.03

1.1

1.0

—

(37208534) Antinuclear antibody arbitrary concentration in serum

129

6.51

50.99

1.0

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

482

2375

2.12

48.56

3.3

2.1

354.21

667.63

ug/l

2.05

461

2266

(4015189) Microbial culture of sputum

148

5.88

47.75

1.8

2.2

—

(3020891) Body temperature

577

3055

1.98

47.73

5.3

4.4

36.94

36.91

°c

1.81

571

3018

(3037756) Immunofixation for Serum or Plasma

353

1541

2.37

47.71

1.6

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

269

1035

2.67

47.49

1.1

4.15

4.03

0.03

(4035726) Immunohistochemistry procedure

840

5040

1.78

46.92

1.4

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

423

2018

2.18

46.25

2.5

2.3

0.00

g/l

0.50

374

1759

(3039744) RNA polymerase III Ab [Units/volume] in Serum

14.09

45.89

1.0

1.1

5.50

1.80

u/ml

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1019

6501

1.68

45.52

3.2

2.7

9.71

9.49

umol/l

0.10

899

5745

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

126

313

4.09

45.40

2.3

2.1

0.57

0.64

e9/l

0.67

114

296

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

203

689

3.01

45.27

1.1

1.58

1.55

g/l

0.36

180

625

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

433

2106

2.14

45.04

2.5

2.3

0.05

0.03

g/l

0.32

395

1885

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

245

924

2.72

44.98

1.3

1.2

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

604

3323

1.91

44.50

2.3

1.7

1.62

1.56

g/l

0.61

523

2862

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

976

6195

1.69

44.33

4.9

3.8

—

(3024354) Oxygen [Partial pressure] in Venous blood

901

5634

1.71

43.17

4.0

3.2

4.51

4.46

kpa

0.23

874

5475

(3014051) Protein [Presence] in Urine by Test strip

1906

14264

1.49

42.16

4.4

3.2

0.03

0.05

0.45

456

(3021788) Differential panel - Synovial fluid

270

1103

2.52

42.15

1.7

1.5

—

1.00

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

390

1881

2.15

41.39

2.6

2.4

0.00

g/l

-0.00

374

1754

(3007930) Methemoglobin/Hemoglobin.total in Blood

521

2794

1.95

41.32

5.9

5.1

0.86

0.16

496

2644

(3047181) Lactate [Moles/volume] in Blood

392

1911

2.13

40.46

7.3

5.9

1.41

1.34

mmol/l

0.74

361

1698

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

9.66

40.34

1.1

1.0

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

480

2525

1.98

40.24

2.5

2.4

10.64

10.22

g/l

1.17

447

2217

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2299

17979

1.45

40.09

3.1

2.7

66.78

65.17

u/l

0.10

2147

16608

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

209

4.60

40.05

1.1

1.2

1.06

1.08

ratio

0.41

163

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

509

2741

1.94

39.84

2.5

2.4

3.10

2.91

g/l

4.28

480

2464

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

163

528

3.15

39.41

1.1

3.24

3.42

0.05

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

534

2933

1.90

39.36

2.4

3.94

3.71

g/l

2.24

503

2656

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

217

4.48

39.14

1.1

1.2

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

534

2940

1.90

39.07

2.4

4.13

4.18

g/l

0.84

506

2662

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

534

2941

1.90

39.03

2.4

7.85

7.43

g/l

5.93

505

2659

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

476

2524

1.96

38.96

2.7

2.4

0.65

0.99

g/l

1.41

421

2145

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

443

2298

2.00

38.61

7.1

4.3

25.02

24.78

mmol/l

0.96

414

2088

(3041096) Erythrocytes [Presence] in Urine by Automated

1888

14295

1.47

38.59

5.4

3.8

0.10

0.27

estimate

0.75

867

4662

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

5279

48784

1.72

38.02

38.5

19.4

25.90

27.41

mg/l

3.34

5041

41387

(3024891) Influenza virus A+B Ag [Presence] in Specimen

263

1118

2.41

37.67

1.3

1.2

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1646

12177

1.49

37.64

2.9

3.2

2.48

2.46

mmol/l

7.73

1513

10889

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

297

1337

2.29

37.31

1.8

1.6

—

(3004809) Band form neutrophils/Leukocytes in Blood

259

1099

2.42

37.24

4.4

3.7

1.68

1.61

0.09

241

964

(3007566) Smooth muscle Ab [Titer] in Serum

300

1364

2.26

36.81

1.3

1.2

133.85

111.85

titre

0.42

108

(3047007) Chlamydophila sp Ab [Presence] in Serum

158

530

3.04

36.00

1.2

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

154

4.99

35.36

1.1

22.15

5.44

u/ml

0.56

(40768797) Stomach Pathology biopsy report

1113

7674

1.55

35.18

1.3

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

178

4.66

35.17

1.4

2.2

202.91

174.13

1.40

170

(3011397) Hemoglobin [Presence] in Urine by Test strip

1755

13301

1.45

34.92

4.8

4.1

0.14

0.50

0.51

156

(3007853) Bacteria identified in Skin by Aerobe culture

987

6663

1.58

34.13

2.1

1.8

—

(3018572) Chloride [Moles/volume] in Blood

286

1328

2.21

33.33

7.2

6.9

103.82

105.05

mmol/l

4.49

263

1188

(3039000) Anion gap in Blood by calculation

286

1328

2.21

33.33

7.2

6.9

11.69

11.23

mmol/l

1.52

263

1187

(3052851) Hemolysis interference index of Serum or Plasma

334

1652

2.08

33.10

4.0

3.5

2.70

1.90

index

1.27

197

848

(3029937) Albumin [Presence] in Urine by Test strip

2055

16154

1.42

33.02

5.7

4.4

0.00

estimate

1.73

931

5398

(3034770) Mitochondria Ab [Titer] in Serum

290

1363

2.19

32.79

1.3

1.2

770.83

1020.00

titre

0.39

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

332

1653

2.07

32.32

1.6

1.4

—

(3018405) Lactate [Moles/volume] in Arterial blood

404

2176

1.92

31.44

4.7

3.8

1.40

1.42

mmol/l

0.18

399

2139

(3026008) Bacteria identified in Urine by Culture

2265

18255

1.39

30.86

3.9

3.6

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

328

1677

2.01

29.67

3.5

2.9

1.83

1.75

mg/l

0.89

304

1494

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1379

10258

1.45

29.38

1.3

1.25

1.66

u/ml

1.19

351

2572

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

113

5.17

28.27

1.1

1.2

92.14

81.64

1.35

(3010838) Calcium [Moles/time] in 24 hour Urine

207

905

2.33

27.85

1.8

4.39

4.61

mmol/24h

0.46

189

776

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

188

794

2.41

27.35

1.2

1.3

213.96

202.46

miu/ml

0.12

287

(3000060) B lymphocytes [#/volume] in Blood

106

5.23

27.14

2.1

1.9

0.12

1.52

e9/l

0.85

(3000012) Reticulocyte production index

226

1045

2.21

26.62

2.7

2.1

0.95

0.86

1.57

168

728

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3553

31192

1.34

26.11

4.7

3.4

65.42

55.39

u/l

4.64

3344

28723

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

118

4.87

25.93

1.1

1.4

94.38

81.22

1.42

(3004119) Hemoglobin [Mass/volume] in Venous blood

642

4168

1.61

25.72

4.6

3.2

126.96

127.85

g/l

0.46

624

4045

(3042111) Morphology [Interpretation] in Bone marrow Narrative

243

1174

2.12

25.62

1.6

1.5

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2497

20848

1.34

25.62

5.6

4.3

0.56

0.36

estimate

0.13

897

4924

(3021960) Folate [Moles/volume] in Serum or Plasma

2196

18017

1.35

25.21

1.9

1.8

19.16

20.01

nmol/l

1.96

1930

15187

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

368

2074

1.83

24.78

1.4

1.3

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

174

747

2.37

24.44

1.1

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

6.04

24.16

1.8

1.6

92.81

108.16

au/ml

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

156

643

2.46

23.97

4.8

4.0

—

(3000475) Leukocytes [#/volume] in Synovial fluid

289

1527

1.94

23.77

1.8

1.6

14825.40

15004.23

e6/l

0.02

203

1061

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

101

4.98

23.43

1.5

1.2

—

(40768804) Tissue Pathology biopsy report

2487

20941

1.32

23.32

2.5

2.3

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

151

4.14

23.08

1.0

1.1

98.64

92.56

1.00

112

(3003327) Ova and parasites identified in Stool by Light microscopy

281

1487

1.93

23.01

1.9

1.7

—

(3045142) Bone marrow Pathology biopsy report

169

739

2.32

22.78

1.5

1.3

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

299

1621

1.89

22.76

1.7

1.5

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

157

669

2.38

22.45

1.7

1.5

58.37

61.52

0.44

435

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

768

5352

1.50

22.21

3.0

2.5

36.17

48.87

u/l

0.77

690

4502

(3003129) Base excess in Capillary blood by calculation

174

779

2.27

22.21

3.4

2.4

0.84

0.35

mmol/l

0.93

167

750

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

132

522

2.56

22.16

1.7

1.8

4.40

4.55

mg/l

0.12

124

499

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

122

4.46

22.15

1.7

1.5

8.14

9.59

ug/l

1.63

122

(3004451) EKG impression Narrative

109

392

2.81

22.04

1.3

—

(3048689) Calprotectin [Mass/mass] in Stool

799

5632

1.48

21.81

2.5

2.2

182.15

161.01

ug/g

0.77

667

4436

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

146

615

2.41

21.43

1.1

4.17

21.37

au/ml

5.10

107

(3036782) Glucose [Moles/volume] in Pleural fluid

167

752

2.26

21.04

1.4

6.64

6.35

mmol/l

0.55

152

701

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

672

4613

1.51

20.82

1.7

1.66

1.56

2.26

570

3884

(3027273) Bicarbonate [Moles/volume] in Venous blood

484

3087

1.62

20.72

4.4

3.4

25.54

25.12

mmol/l

1.58

463

2984

(3003329) Lymphocytes/Leukocytes in Synovial fluid

127

513

2.51

20.43

1.9

1.4

37.75

27.64

2.15

323

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

528

3457

1.58

20.24

4.1

2.8

0.64

0.62

0.66

528

3442

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

168

771

2.21

20.23

1.4

1.3

468.44

333.58

u/l

1.59

156

730

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

4.67

20.04

2.4

2.0

7.36

9.10

mg/l

1.15

(3044242) Glucose [Moles/volume] in Arterial blood

109

413

2.67

19.98

1.9

8.17

8.22

mmol/l

0.04

109

413

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

120

4.28

19.89

1.0

—

(3040151) Glucose [Moles/volume] in Capillary blood

167

770

2.20

19.88

10.2

16.1

7.59

7.36

mmol/l

0.33

147

645

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

142

3.97

19.79

2.2

2.4

1.85

2.07

ratio

0.31

130

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

190

927

2.08

19.58

1.2

1.3

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

686

4792

1.49

19.47

4.7

4.0

103.52

97.05

ng/l

0.76

605

4062

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

139

599

2.35

19.43

1.3

15.27

12.92

u/l

0.58

123

550

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

132

556

2.41

19.42

1.6

1.4

14.13

13.22

u/l

0.73

126

534

(3025941) Bacteria identified in Stool by Culture

402

2491

1.66

19.29

1.3

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

183

893

2.08

18.86

6.9

6.3

12.01

12.25

mg/l

0.33

171

827

(3000093) Morphology [Interpretation] in Blood Narrative

141

622

2.30

18.69

1.2

1.1

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

133

574

2.35

18.54

1.2

69.18

65.29

u/l

0.25

119

500

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2901

25443

1.27

18.18

3.7

2.9

—

estimate

—

(3012441) Differential panel - Pleural fluid

173

839

2.09

18.14

1.5

—

(3026389) Candida sp identified in Specimen by Organism specific culture

147

674

2.21

17.78

1.4

—

(3003434) Protein [Mass/volume] in Pleural fluid

212

1116

1.93

17.69

1.5

32.47

31.30

g/l

0.63

182

1003

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

105

419

2.53

17.39

1.3

1.2

99.51

100.05

pmol/l

0.04

105

419

(3019309) Folate [Moles/volume] in Red Blood Cells

1429

11492

1.32

17.37

1.9

1.8

1168.27

1156.66

nmol/l

0.16

1085

8624

(3034891) Synovial lining cells/cells in Synovial fluid

258

2.97

17.15

1.7

1.4

3.84

4.07

0.06

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

4.83

16.81

1.2

119.87

1127.58

ng/l

0.49

(3017354) Segmented neutrophils/Leukocytes in Blood

149

704

2.15

16.75

4.4

3.6

56.16

58.22

0.55

131

590

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

330

2.69

16.53

1.6

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

330

2.69

16.53

1.6

1.4

—

(3045424) Erythrocytes [Presence] in Urine

431

2832

1.56

16.21

2.5

2.2

0.09

0.33

estimate

0.32

142

778

(40768446) Kidney Pathology biopsy report

181

3.28

15.81

1.5

1.6

—

(3019832) Treponema pallidum Ab [Presence] in Serum

322

1988

1.66

15.68

1.4

1.6

—

(40768795) Lymph node Pathology biopsy report

125

566

2.23

15.64

1.5

1.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

103

4.10

15.58

1.5

1.4

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

4073

37556

1.27

15.38

4.5

4.3

14.98

15.02

pmol/l

0.54

3735

33893

(40768806) Pleura Pathology biopsy report

163

823

2.01

15.38

1.5

1.6

—

(3024928) Oxygen saturation in Venous blood

276

1650

1.71

15.18

4.4

3.0

63.41

59.95

1.71

269

1595

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

387

2519

1.57

15.17

2.7

2.0

—

(40768443) Skin Pathology biopsy report

395

2584

1.57

15.15

1.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

101

426

2.39

14.91

1.1

1.35

1.09

u/ml

0.17

227

(3045788) Cell count panel - Pleural fluid

154

772

2.02

14.84

1.5

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

157

794

2.00

14.76

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

281

2.73

14.72

4.5

3.5

1.13

1.35

0.51

281

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

126

589

2.16

14.60

1.1

1.20

1.97

u/ml

0.64

329

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

278

1684

1.68

14.57

1.4

1.3

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

400

2.42

14.57

1.3

1.2

—

(3020682) Albumin/Creatinine [Ratio] in Urine

2344

20407

1.25

14.40

4.8

4.2

11.46

9.29

mg/mmol

1.29

1530

12933

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

626

4543

1.42

14.36

3.7

2.8

54.54

61.48

ml/min/173m2

5.60

325

1996

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2961

26449

1.24

14.34

2.4

2.3

92.04

94.04

pmol/l

1.50

1675

14205

(21494567) Legionella sp IgM Ab [Presence] in Serum

6.17

14.18

1.1

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

6.17

14.18

1.1

1.0

—

(3023183) Ammonium ion [Moles/volume] in Plasma

233

1365

1.74

13.81

2.7

2.5

32.83

33.87

umol/l

0.27

221

1216

(3027456) Digoxin [Moles/volume] in Serum or Plasma

261

1579

1.68

13.76

3.3

0.87

0.82

nmol/l

0.85

214

1261

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1506

12513

1.27

13.72

1.9

1.8

30178467.34

26144029.14

pmol/l

0.10

1236

10209

(3050794) Legionella sp Ab [Presence] in Serum

5.31

13.69

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

228

1334

1.74

13.58

1.3

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

4.32

13.55

1.0

1.4

93.27

76.25

0.83

(3014133) Dog dander IgE Ab [Units/volume] in Serum

378

2.40

13.45

1.1

2.54

2.09

u/ml

0.18

196

(3019550) Sodium [Moles/volume] in Serum or Plasma

5287

50705

1.38

13.44

40.4

23.8

139.08

139.63

mmol/l

41.43

5249

49709

(3009508) Creatinine [Moles/volume] in Urine

2329

20378

1.23

13.35

4.0

3.5

7.06

7.33

mmol/l

2.83

1954

16945

(3012516) Albumin [Mass/volume] in Urine

2280

19949

1.23

12.95

4.0

3.5

64.13

52.11

mg/l

1.56

1549

13060

(3000570) Elastase.pancreatic [Mass/mass] in Stool

285

1795

1.62

12.85

1.5

286.97

262.40

ug/g

0.46

172

1102

(3023103) Potassium [Moles/volume] in Serum or Plasma

5288

50779

1.37

12.78

40.8

24.0

4.02

4.00

mmol/l

5.34

5243

49707

(3023430) Cat dander IgE Ab [Units/volume] in Serum

351

2.41

12.72

1.1

1.22

2.86

u/ml

1.26

157

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

4.19

12.68

1.1

1.3

76.70

82.12

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

104

481

2.18

12.44

1.1

3.05

3.27

u/ml

0.07

237

(3051611) Lipemic interference index of Serum or Plasma

120

592

2.05

12.15

4.7

3.4

14.22

12.00

index

1.47

319

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

404

2.27

12.03

1.3

1.1

—

(3019230) Fractional oxyhemoglobin in Venous blood

228

1387

1.67

11.81

4.8

2.6

63.41

61.03

0.87

228

1381

(3017704) Immunofixation for Urine

382

2.30

11.81

1.3

1.5

—

(3013727) Leukocytes other/Leukocytes in Blood

204

2.81

11.81

4.7

3.8

58.27

54.53

0.59

196

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

5.37

11.80

1.0

—

(44806071) Cardiolipin IgM antibody measurement

4.92

11.66

1.0

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

312

2.42

11.51

1.1

1.0

0.23

u/ml

0.00

126

(36660697) Celiac disease serology panel - Serum

504

3659

1.41

11.49

1.2

—

(3022145) Colonoscopy Study observation

795

6218

1.32

11.28

1.4

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

4914

46871

1.28

11.20

33.7

19.5

73.09

74.19

ml/min/173m2

3.28

4710

43885

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

305

2.41

11.11

1.2

1.1

30.52

29.40

u/l

0.06

268

(3023199) Leukocytes [#/volume] in Pleural fluid

169

963

1.78

11.10

1.5

4937.59

2854.41

e6/l

0.37

105

681

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

337

2.33

11.02

1.1

1.2

116.04

94.94

u/l

0.49

282

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

212

2.70

11.01

1.2

1.1

10.19

18.66

u/ml

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

325

2.36

10.99

1.1

1.2

53.71

25.76

u/l

1.17

268

(3008401) Mugwort IgE Ab [Units/volume] in Serum

473

2.11

10.96

1.1

0.71

1.25

u/ml

0.61

208

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

309

2.38

10.81

1.2

1.1

86.00

87.06

u/l

0.03

272

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

341

2347

1.48

10.35

2.3

1.8

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

335

2.29

10.28

1.1

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

9.55

10.23

1.3

1.2

1.00

1.15

iu/ml

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

109

558

1.97

10.04

1.1

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

335

2324

1.47

9.78

1.1

0.88

1.21

u/ml

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

9.53

9.74

1.5

1.2

0.98

1.32

mg/l

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

9.53

9.74

1.5

1.2

5.33

2.11

mg/l

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

9.53

9.74

1.5

1.2

1.77

2.95

mg/l

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

9.53

9.74

1.5

1.2

1.43

3.34

mg/l

0.60

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

9.53

9.74

1.5

1.2

3.99

1.16

mg/l

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

9.53

9.74

1.5

1.2

2.19

2.31

mg/l

0.02

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

9.53

9.74

1.5

1.2

2.08

0.69

mg/l

0.50

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

9.53

9.74

1.5

1.2

1.93

1.27

mg/l

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

9.53

9.74

1.5

1.2

0.78

0.95

mg/l

—

(3044927) Protein electrophoresis panel - Urine

129

706

1.85

9.73

1.2

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

257

2.43

9.65

1.0

1.1

9.57

11.80

iu/ml

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

149

855

1.76

9.61

1.5

124804.46

57852.33

e6/l

0.87

488

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

9.07

9.50

1.5

1.2

0.41

2.05

mg/l

—

(3035880) pH of Pleural fluid

420

2.09

9.43

1.3

7.37

7.41

0.79

284

(3044640) Blood type and Crossmatch panel - Blood

2068

18338

1.20

9.34

3.4

2.7

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

330

2.23

9.34

1.5

1.6

8.64

7.05

u/l

0.43

265

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5267

50917

1.30

9.19

24.4

13.2

24.66

25.54

u/l

3.41

5220

49171

(3023383) Lactate [Moles/volume] in Pleural fluid

234

2.45

9.08

1.3

3.76

3.43

mmol/l

0.30

212

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

112

602

1.88

8.97

2.9

3.3

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

4738

45281

1.23

8.94

5.8

5.4

2.07

2.02

mu/l

1.32

4385

41165

(3012565) Volume of 24 hour Urine

267

2.34

8.90

2.0

2.4

1812.47

1854.67

0.15

227

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

715

5686

1.29

8.89

1.5

1.4

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

190

2.59

8.80

1.1

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

3.28

8.73

2.6

3.6

7.72

7.39

mg/l

0.08

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

152

2.78

8.62

5.6

7.9

6.08

6.00

kpa

0.15

134

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

11.56

8.56

1.3

0.63

0.13

iu/ml

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

4880

46838

1.23

8.52

7.9

7.3

40.91

40.28

mmol/mol

4.68

4595

43187

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

142

2.83

8.51

1.6

0.33

0.40

ug/l

0.64

(3041918) Cholesterol [Moles/volume] in Pleural fluid

148

2.78

8.46

1.2

1.76

1.50

mmol/l

0.66

(21494434) Karyotype in Bone marrow

109

594

1.85

8.39

1.4

1.2

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

4.30

8.39

1.3

1.7

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

256

2.32

8.35

7.1

3.8

70.63

66.71

mg/l

0.13

178

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

117

3.00

8.29

1.3

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

3.62

8.27

1.2

1.4

300009.34

129515.57

nmol/l

0.22

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

426

3182

1.36

8.20

2.5

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

540

6882

0.76

8.06

9.7

8.0

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

10.02

8.01

1.2

1.1

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

712

5733

1.27

8.00

2.7

2.4

11.73

7.11

ug/l

4.86

630

4997

(3016750) Collection duration of Urine

331

2.10

7.69

2.1

471.31

495.81

min

0.94

230

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1598

14051

1.19

7.60

3.3

2.6

—

(3020961) Endomysium IgA Ab [Titer] in Serum

274

1927

1.44

7.51

1.1

289.29

181.76

titre

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

255

1771

1.46

7.47

1.6

0.37

0.33

mg/l

0.49

119

787

(3025018) Bordetella pertussis Ab [Titer] in Serum

244

2.27

7.44

1.1

1.2

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

5311

51605

1.27

7.39

44.8

26.1

88.46

83.93

umol/l

9.87

5280

50893

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

285

2.15

7.29

1.4

1.2

—

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

116

2.86

7.19

1.2

1.6

3.73

8.09

1.43

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

3.39

6.96

1.2

0.04

0.60

u/ml

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

443

1.89

6.89

1.6

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

312

2.06

6.88

1.8

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

312

2.06

6.88

1.8

1.3

—

(3020491) Glucose [Moles/volume] in Blood

389

1.94

6.79

2.1

2.2

7.38

6.88

mmol/l

0.94

260

(40761539) Cells [Type] in Urine sediment by Light microscopy

137

2.64

6.79

1.3

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

282

2.10

6.69

1.4

1.2

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

368

2776

1.35

6.69

2.7

3.4

4.23

4.40

pmol/l

2.31

323

2439

(3003181) Sodium [Moles/volume] in Urine

183

1219

1.52

6.63

1.4

64.29

61.67

mmol/l

0.42

161

987

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

449

1.86

6.63

1.7

1.3

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

393

1.92

6.60

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

163

2.46

6.58

1.3

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

134

2.62

6.53

5.3

7.9

5.63

5.45

kpa

0.17

134

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

3.81

6.52

1.3

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

3.81

6.52

1.3

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

3.81

6.52

1.3

—

(3001893) Eosinophils/Leukocytes in Pleural fluid

235

2.18

6.36

1.5

2.65

2.40

0.08

201

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

8.14

6.32

1.8

1.3

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

3.45

6.27

1.3

1.0

10.42

9.82

iu/ml

0.04

(21494890) Protein electrophoresis panel - 24 hour Urine

120

739

1.64

6.12

1.8

2.0

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

161

1064

1.53

6.08

1.1

19.85

8.61

eliau/ml

0.66

(44813793) Dust mix specific IgE antibody measurement

273

2.06

6.06

1.1

1.0

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

533

1.74

5.91

1.3

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

166

2.36

5.87

1.1

14.30

2.09

u/ml

1.10

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

5.34

5.83

2.0

1.21

1.44

mg/l

0.43

(3006576) Bicarbonate [Moles/volume] in Blood

192

2.25

5.81

5.7

7.3

24.41

24.65

mmol/l

0.13

174

(3030981) Hyaline casts [#/volume] in Urine by Automated count

641

5297

1.24

5.73

3.5

2.6

0.47

0.50

e6/l

0.09

619

5114

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

804

6806

1.21

5.66

3.3

4.3

12.54

26.90

ug/l

1.80

673

5661

(3045414) Leukocytes [Presence] in Urine

675

5616

1.23

5.65

2.6

2.2

0.01

0.00

estimate

0.36

169

1037

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

209

2.16

5.55

3.4

2.4

4.63

4.88

kpa

1.21

209

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

210

2.15

5.48

3.4

2.4

9.20

10.11

kpa

1.68

210

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

129

2.49

5.43

1.2

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.10

5.33

1.0

1.7

—

(3034459) Mononuclear cells/Leukocytes in Pleural fluid

2.92

5.29

1.4

68.06

74.23

0.39

(3007919) Fasciola sp Ab [Titer] in Serum

11.26

5.28

1.3

1.1

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

288

1.95

5.28

1.4

1.5

66.09

68.64

0.18

239

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

208

2.12

5.21

2.8

2.5

0.61

mmol/l

0.10

208

(3024731) MCV [Entitic mean volume] in Red Blood Cells

5324

52027

1.22

5.21

51.6

29.3

92.66

91.71

36.27

5295

51330

(3004775) Volume in Urine collected for unspecified duration

478

1.73

5.20

2.2

574.09

655.66

1.23

292

(3035941) MCH [Entitic mass]

5324

52028

1.22

5.20

51.6

29.3

30.53

30.46

1.71

5296

51332

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

375

1.82

5.20

1.0

294.93

288.03

mg/l

0.32

337

(3026361) Erythrocytes [#/volume] in Blood

5324

52030

1.22

5.19

51.7

29.4

4.35

4.41

e12/l

15.62

5240

50617

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

5324

52031

1.22

5.18

53.6

29.9

39.67

39.82

1.27

5295

51313

(3010813) Leukocytes [#/volume] in Blood

5324

52034

1.22

5.16

51.8

29.4

7.78

6.90

e9/l

63.30

5245

50604

(3002523) Influenza virus A Ag [Presence] in Specimen

517

1.69

5.15

1.1

—

(3007461) Platelets [#/volume] in Blood

5323

52025

1.22

5.14

51.9

29.4

244.04

240.99

e9/l

2.52

5256

50812

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

115

734

1.58

5.14

1.7

1.4

—

(3000963) Hemoglobin [Mass/volume] in Blood

5324

52038

1.22

5.13

52.2

29.6

131.16

133.35

g/l

20.83

5298

51370

(3026051) Granulocytes/Leukocytes in Pleural fluid

177

2.21

5.11

1.2

1.4

24.65

22.17

0.19

147

(3005988) Vibrio sp identified in Specimen by Organism specific culture

115

737

1.57

5.05

1.7

1.4

—

(3035320) C reactive protein [Mass/volume] in Body fluid

423

1.76

5.04

3.1

2.8

33.08

33.05

mg/l

0.00

318

(3042010) Triglyceride [Moles/volume] in Pleural fluid

122

2.47

5.03

1.2

0.40

2.00

mmol/l

1.54

(40771922) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by based on 1.73 sq M

3.67

4.92

1.3

0.82

0.76

ml/s/173m2

—

(3047189) Immunofixation for 24 hour Urine

354

1.82

4.87

1.7

1.6

—

(3003740) Influenza virus B Ag [Presence] in Specimen

518

1.67

4.87

1.2

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

578

6901

0.82

4.83

5.2

5.4

32.20

33.25

1.49

415

4441

(3003694) ABO and Rh group [Type] in Blood

1520

13719

1.14

4.80

1.5

1.3

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

113

733

1.55

4.74

1.7

1.4

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

108

2.51

4.70

1.2

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

2.84

4.64

1.0

1.1

14.95

6.69

u/ml

0.54

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

109

2.48

4.61

1.3

1.2

27.41

341.76

u/l

0.58

(3044416) Complement C4 [Mass/volume] in Pleural fluid

3.49

4.61

1.2

1.1

0.09

0.07

g/l

—

(3020876) Protein [Mass/time] in 24 hour Urine

132

893

1.49

4.57

2.4

2.3

0.96

1.21

g/24h

0.76

525

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

5.23

4.45

6.7

9.7

110.08

104.74

g/l

0.66

(3019768) Coxiella burnetii Ab [Presence] in Serum

4.38

4.43

1.4

1.3

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

4.49

4.24

2.2

1.8

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

578

1.58

4.22

1.7

1.3

92463.31

131501.67

e6/l

0.27

386

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

6.93

4.16

1.1

1.0

—

(3011325) HIV 1+2 Ab [Presence] in Serum

6.93

4.16

1.1

1.0

0.08

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

359

1.73

4.11

2.0

1.8

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

114

770

1.49

4.02

1.7

1.4

—

(3016135) IgD [Mass/volume] in Serum

10.01

4.01

1.3

1.4

184.86

44.89

mg/l

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

5.56

3.97

1.0

1.9

—

(3020393) Adenovirus Ag [Presence] in Stool

3.02

3.96

1.2

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

3.02

3.96

1.0

1.1

—

(3008295) Osmolality of Serum or Plasma

652

1.53

3.94

1.4

1.3

272.61

276.61

mosm/kgh2o

0.90

485

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

115

782

1.48

3.93

1.7

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

113

766

1.48

3.93

1.7

1.4

—

(3006969) Lambda light chains [Mass/volume] in Urine

4.79

3.86

1.0

0.25

0.12

g/l

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

162

1180

1.38

3.82

1.2

1.3

44.50

39.03

u/l

0.15

143

1017

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.84

3.78

1.8

1.6

—

(3024263) Appearance of Synovial fluid

316

1.75

3.77

2.1

1.6

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

4879

47571

1.14

3.76

6.0

5.8

6.08

6.09

mmol/l

0.09

4455

42987

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

237

3031

0.77

3.70

2.2

2.1

3.74

3.44

ratio

0.48

194

2450

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

3.83

3.68

1.5

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

138

987

1.41

3.64

1.4

32.01

29.45

iu/l

0.36

106

835

(3037121) Protein [Mass/volume] in Urine

264

2083

1.28

3.61

2.9

3.2

356.16

418.91

mg/l

0.46

138

930

(42529406) Shigella sp [Presence] in Stool by Culture

181

1358

1.34

3.57

1.3

1.2

—

(3019150) Specific gravity of Urine by Refractometry

1379

12578

1.13

3.57

5.5

4.6

1.02

1.13

kg/l

0.50

1017

8644

(3014765) Yersinia sp identified in Stool by Organism specific culture

180

1350

1.34

3.56

1.3

1.2

—

(40757494) Bilirubin.total [Moles/volume] in Blood

322

1.71

3.55

2.3

2.6

23.36

32.56

umol/l

—

(42528597) U1 small nuclear ribonucleoprotein C Ab [Presence] in Serum by Line blot

7.79

3.55

1.0

—

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

7.79

3.55

1.0

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

159

2135

0.74

3.54

2.0

1.8

3.25

3.39

mmol/l

0.76

116

1552

(3008116) Ketones [Moles/volume] in Urine by Test strip

138

2.11

3.48

1.5

0.42

0.37

mmol/l

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

178

1339

1.34

3.46

1.3

1.2

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

4.55

3.42

1.0

1.7

—

(3008898) HLA-B27 [Presence]

158

1170

1.36

3.41

1.1

—

(44786800) Granulocytes/Leukocytes in Body fluid

2.35

3.40

1.3

14.07

20.51

0.38

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

312

1.70

3.38

1.8

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

255

1.77

3.28

1.3

92.04

466.44

ug/l

1.20

125

(3036670) Protein [Mass/volume] in Synovial fluid

198

1.87

3.24

1.2

33.26

40.37

g/l

2.33

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

198

1.87

3.24

1.1

1460.07

1597.48

miu/ml

0.27

198

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

4.74

3.23

1.1

1.0

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

536

1.52

3.23

1.5

1.6

13.55

27.03

u/ml

2.54

109

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

287

1.71

3.20

3.2

3.1

215.22

207.66

u/l

0.36

280

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

5.34

3.19

1.3

1.0

—

(3001729) Color of Synovial fluid

2.73

3.15

2.5

1.6

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

3.25

3.13

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.96

3.13

1.2

1.3

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

2.68

3.05

3.0

2.7

0.70

1.36

mg/l

—

(21494755) Public health laboratory ask at order entry panel

165

2150

0.76

3.03

1.4

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

106

2.17

3.02

1.4

1.3

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

623

1.45

2.91

1.2

1.3

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

142

1.98

2.89

1.3

0.34

0.30

g/l

1.35

110

(3010370) Gastrin [Moles/volume] in Serum or Plasma

2.34

2.81

1.3

1.9

54.11

37.14

pmol/l

0.50

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

103

2.14

2.80

4.7

7.6

11.05

10.17

1.18

103

(40758292) HTLV I+II Ab panel - Serum

2.23

2.79

1.3

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.58

2.78

1.1

1.0

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

262

1.68

2.75

1.1

1.6

6.11

11.46

umol/l

1.32

183

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

124

2.02

2.75

1.2

1.1

—

(40765096) Chromosome analysis panel by Banding

211

1.76

2.70

1.2

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

227

1.72

2.65

1.3

—

(3020650) Glucose [Presence] in Urine

154

1.89

2.65

2.0

1.8

0.00

0.06

estimate

1.08

154

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

479

1.49

2.65

2.1

1.8

4300.01

3645.95

u/l

0.07

180

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

357

3020

1.19

2.63

1.3

56.85

60.51

au/ml

0.08

209

(3009214) Lutropin [Units/volume] in Serum or Plasma

126

943

1.34

2.62

1.4

10.58

10.29

u/l

0.09

103

758

(3005011) Chlamydia sp Ab [Titer] in Serum

2.55

2.61

1.4

1.7

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

4.67

2.59

2.7

4.7

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

214

1724

1.25

2.56

1.6

40.18

22.90

u/ml

0.53

309

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

2.23

2.53

1.2

25.40

20.54

u/l

—

(3002256) Pathology report gross observation

831

7509

1.12

2.50

1.4

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

106

779

1.37

2.50

3.0

2.1

28.88

26.25

mg/l

0.19

263

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

3.81

2.46

1.3

1.7

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

220

1788

1.24

2.45

1.4

1.3

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

385

3302

1.18

2.44

2.4

2.5

34.86

22.81

au/ml

0.94

258

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

310

2612

1.20

2.41

1.2

124.76

133.92

u/ml

0.16

902

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

4626

45264

1.10

2.39

4.8

4.6

1.34

1.27

mmol/l

8.60

4154

40748

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

212

1.70

2.38

2.7

1.9

179.25

105.40

umol/l

0.33

123

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

6.25

2.37

1.0

—

(3041184) Isoniazid [Presence] in Urine

6.25

2.37

2.6

1.5

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

2.07

2.36

1.2

1.1

1440.00

888.46

titre

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

290

1.59

2.35

1.5

1.7

1.78

2.24

u/field

0.26

195

(40768441) Liver Pathology biopsy report

378

1.51

2.34

1.5

1.3

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

464

1.45

2.24

1.4

124.00

347.17

titre

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

5.56

2.21

1.2

1.0

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.05

2.21

9.4

14.2

5.48

5.02

mmol/l

0.49

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.86

2.20

1.0

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

107

1.97

2.20

1.2

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

143

1.82

2.18

1.3

37.62

34.01

0.18

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

512

1.41

2.11

1.7

2.0

1.37

1.31

u/field

0.06

273

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

2.14

2.08

1.6

1.3

109.73

121.86

ug/l

—

(3049717) Cytology report of Urine Cyto stain

328

2819

1.17

2.07

3.0

2.9

—

(3016038) Potassium [Moles/volume] in Urine

441

1.43

2.02

1.3

1.1

33.32

34.71

mmol/l

0.22

383

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

542

1.39

2.02

1.3

1.4

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

780

0.69

2.01

1.1

1.2

0.62

0.61

ratio

0.03

129

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.63

2.00

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

468

1.41

1.98

1.0

1.1

14.75

2.85

eliau/ml

0.80

155

(3001186) Copper [Moles/volume] in Serum or Plasma

126

1.83

1.97

1.7

1.2

16.44

15.99

umol/l

0.17

111

(3020191) Ethanol [Moles/volume] in Serum or Plasma

394

1.45

1.96

1.2

1.3

1.07

1.06

promille

0.02

307

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4934

48536

1.10

1.96

6.5

6.4

2.45

2.54

mmol/l

9.73

4510

44415

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

691

1.34

1.96

1.5

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

249

1.57

1.94

1.3

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

4.55

1.94

1.0

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

218

1.61

1.93

1.3

1.2

—

(3044009) aPTT.lupus sensitive (LA screen)

2.73

1.93

1.3

1.2

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

2.24

1.90

1.1

—

(3048879) Bone marrow aspiration report

190

1.63

1.83

2.1

1.7

—

2.00

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

318

1.48

1.82

1.5

1.3

1.24

1.18

nmol/l

0.13

226

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

115

1.83

1.82

1.1

1.2

0.86

89.06

mg/l

0.80

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.27

1.80

1.3

1.7

—

(3044007) Cell count panel - Peritoneal fluid

199

1.61

1.79

1.4

1.8

—

(3000919) Neutrophils/Leukocytes in Pleural fluid

215

1.58

1.78

1.5

1.4

26.47

19.83

0.58

198

(3001019) Free T4 and TSH panel - Serum or Plasma

1251

0.78

1.68

1.8

1.7

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

2.80

1.65

2.3

5.4

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.80

1.65

3.3

2.7

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4827

47526

1.08

1.64

5.7

5.5

4.34

4.43

mmol/l

7.12

4412

43666

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.44

1.64

1.2

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

198

1.57

1.59

1.0

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

761

0.73

1.53

1.5

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

3.34

1.52

1.0

1.1

0.01

0.04

u/ml

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.83

1.51

1.4

1.3

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

870

0.76

1.48

1.2

1.53

1.52

g/l

0.16

870

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

4786

47164

1.08

1.45

5.6

5.4

1.40

1.43

mmol/l

5.98

4337

42993

(3036525) Urea [Moles/time] in 24 hour Urine

2.37

1.45

3.8

3.5

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

3.13

1.44

2.0

2.5

2.32

3.20

mg/l

—

(3023511) Choriogonadotropin [Units/volume] in Urine

189

1.54

1.39

1.3

1.2

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.08

1.38

1.0

—

(4034850) Laboratory test

187

1597

1.18

1.37

13.9

11.7

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.20

1.36

1.0

1.1

96.00

90.54

titre

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

272

1.44

1.36

1.6

1.7

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

109

888

1.23

1.32

1.3

1.8

302.47

290.75

mu/l

0.16

822

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.04

1.32

1.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.97

1.32

1.2

1.0

17.84

46.59

iu/ml

2.26

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

121

1.66

1.30

1.2

1.1

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

217

1.48

1.30

1.2

0.59

0.54

ratio

0.19

128

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

125

1036

1.21

1.29

1.8

1.6

1.08

0.83

nmol/l

2.47

102

867

(3039443) Prostate specific Ag panel - Serum or Plasma

873

0.78

1.29

1.6

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.89

1.28

2.2

1.4

37.77

45.25

umol/l

0.68

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

218

0.55

1.27

1.5

1.80

1.12

ratio

—

141

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

218

0.55

1.27

1.5

1.46

1.24

ratio

—

141

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

218

0.55

1.27

1.5

0.95

ratio

—

141

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

1.82

1.25

1.7

1.2

23.49

20.12

mmol/l

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.40

1.24

1.0

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

216

0.55

1.24

1.5

—

(3016018) Differential panel - Cerebral spinal fluid

566

1.28

1.21

1.3

—

(3050129) First trimester maternal screen panel - Serum or Plasma

251

0.60

1.20

1.3

1.5

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

269

2392

1.13

1.17

3.2

3.4

161.82

2474.73

u/ml

1.30

223

2073

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

133

1.58

1.17

1.1

1.3

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

282

1.39

1.16

1.1

—

(3040893) Potassium [Moles/volume] in Capillary blood

2.50

1.15

1.2

1.9

4.18

4.44

mmol/l

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.50

1.15

1.0

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

142

1.55

1.14

2.5

4.29

295.87

ug/l

0.81

142

(3002331) Protein [Mass/volume] in Peritoneal fluid

152

1.52

1.08

1.1

1.4

276.45

26.54

g/l

0.48

124

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

711

1.23

1.08

1.2

1.3

313.71

287.76

pmol/l

0.29

582

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

186

1.45

1.05

1.0

1.1

—

(3019174) dRVVT (LA screen)

2.12

1.05

1.4

1.2

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

2.12

1.05

3.6

4.6

—

0.00

estimate

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1822

18862

0.95

1.04

4.5

5.0

22.26

22.30

0.03

852

10201

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.27

1.03

1.0

1.5

—

(3032057) Clostridioides difficile [Presence] in Stool

146

1.51

1.03

2.0

1.9

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.83

1.02

1.7

2.6

0.36

0.40

u/field

0.06

(3043410) Blood group antigens tested for on Red Blood Cells

171

1.46

1.02

2.0

1.9

—

(1002224) Polysomnography panel

186

1634

1.14

1.01

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

247

1.38

1.01

1.0

1.1

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

3929

38654

1.05

0.99

45.2

25.5

329.27

331.62

g/l

48.01

3913

38395

(40758358) Immune stain study

2.17

0.98

1.0

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

148

1.49

0.97

1.2

24.05

12.49

mm/h

1.62

148

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

161

1407

1.15

0.96

3.0

3.4

239.33

907.43

u/ml

1.61

141

1284

(1761482) Bacteria [#/volume] in Urine by Culture

138

1590

0.86

0.94

5.2

4.4

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.89

0.94

1.0

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

184

0.60

0.92

1.5

1.6

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

1.73

0.92

1.0

1.2

—

mmol/l

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

735

1.20

0.91

1.1

68.39

286.30

iu/ml

0.46

143

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

281

1.32

0.86

1.0

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

161

1.43

0.86

1.1

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

148

1301

1.14

0.84

1.3

706.17

574.29

mg/l

0.33

139

1234

(4198724) Urine methamphetamine measurement

1.56

0.84

1.1

1.5

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

446

0.76

0.84

1.1

1.0

370.17

324.05

ng/l

0.34

301

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

112

0.54

0.83

1.5

55.10

51.34

ug/l

—

112

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

131

1144

1.15

0.82

1.2

3.88

3.85

mmol/l

0.12

123

1076

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

165

1464

1.13

0.82

2.5

2.3

131.00

97.21

ug/min

0.58

103

836

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

662

1.20

0.82

1.5

1.3

0.19

0.22

nmol/l

0.41

539

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.70

0.80

1.0

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

231

2093

1.11

0.80

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

176

0.62

0.79

1.4

1.5

—

(40768800) Prostate Pathology biopsy report

146

1650

0.88

0.79

1.2

—

(40768793) Breast Pathology biopsy report

121

1056

1.15

0.78

1.5

1.4

—

(3032773) Endomysium IgG Ab [Titer] in Serum

429

1.24

0.78

1.0

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

199

1.36

0.78

1.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.77

0.0

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

125

0.56

0.77

1.0

1.1

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

475

1.22

0.77

1.1

—

25.21

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

449

0.78

0.75

1.1

1.0

38.97

42.48

ng/l

0.17

300

(3025130) Human papilloma virus identified in Specimen

395

1.24

0.75

1.9

1.8

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.60

0.74

1.0

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

116

1.47

0.74

1.5

1.3

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

447

0.78

0.73

1.1

1.0

822.17

694.69

ng/l

1.15

294

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

172

0.64

0.73

1.7

1.6

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

231

0.69

0.73

1.1

1298.80

302.71

ng/l

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.00

0.72

1.0

1.4

—

(3000330) Specific gravity of Urine by Test strip

293

3173

0.92

0.72

4.5

3.6

1.02

ratio

0.75

275

2883

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

317

1.26

0.71

1.1

48.01

45.32

mg/l

0.16

270

(3033705) Calcium.ionized [Moles/volume] in Venous blood

776

1.16

0.70

3.5

2.4

1.19

1.20

mmol/l

0.42

767

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2123

20731

1.04

0.70

2.1

2.0

1.39

1.32

mmol/l

4.71

1735

17094

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

276

2546

1.09

0.69

1.4

1.3

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

319

1.26

0.69

2.3

2.1

66.00

200.49

ug/min

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.67

0.68

1.0

1.2

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

231

1.30

0.67

1.1

1.2

53.40

67.03

—

(3041354) Potassium [Moles/volume] in Venous blood

791

1.15

0.65

3.5

2.4

4.12

4.10

mmol/l

0.23

782

(3035285) Chloride [Moles/volume] in Venous blood

791

1.15

0.65

3.5

2.4

105.58

105.60

mmol/l

0.01

782

(3014891) Appearance of Pleural fluid

103

1.46

0.64

1.5

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

112

1.43

0.63

1.1

1.09

0.56

u/ml

—

(3052592) Norovirus Ag [Presence] in Stool

129

1.40

0.63

1.8

1.3

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

261

1.27

0.62

1.4

1.5

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

121

1.41

0.62

1.4

1.1

305.00

263.09

pmol/l

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

121

1.41

0.62

2.2

2.1

—

(3051101) Glucose [Moles/volume] in Cord blood

104

0.58

0.61

9.2

5.9

8.73

8.30

mmol/l

—

104

(40765089) Chromosome analysis panel - Blood by G-banded

1.60

0.61

1.0

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.60

0.61

1.0

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

156

1.35

0.60

1.1

1.5

15.67

17.46

pmol/l

0.44

125

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

148

1.35

0.59

1.2

21.67

24.10

—

(3026480) Teichoate Ab [Titer] in Serum

1.54

0.59

1.0

1.1

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.59

0.0

1.0

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

0.00

0.58

0.0

1.1

—

255.87

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

863

0.87

0.58

2.0

1.9

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

604

1.16

0.57

1.4

1.3

1.51

1.49

nmol/l

0.06

539

(3032868) Hemoglobin electrophoresis panel in Blood

1.67

0.56

1.3

1.4

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2383

23395

1.03

0.56

5.4

6.2

3.26

3.52

ug/l

0.15

2121

20999

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

123

1106

1.11

0.55

1.2

1.4

16.72

29.71

e6/l

0.55

815

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

720

0.86

0.55

1.6

1.9

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

124

1117

1.11

0.54

1.3

1.4

229.05

900.78

e6/l

2.53

876

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.39

0.50

1.0

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

493

4707

1.05

0.49

2.7

2.2

12.60

12.61

nmol/l

0.01

434

4140

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

180

1.28

0.49

1.3

1.2

5.89

12.53

pmol/l

—

(3025577) Chromium [Mass/volume] in Blood

408

1.18

0.49

1.9

2.2

1.69

2.12

ug/l

1.04

340

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.43

0.49

2.1

1.7

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

671

1.13

0.48

1.1

—

(3023410) Appearance of Cerebral spinal fluid

493

1.16

0.48

1.3

1.5

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

119

1.35

0.48

2.3

2.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

235

1.24

0.48

1.4

2.1

567.64

4046.13

e6/l

0.54

165

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

757

1.12

0.47

1.5

1.3

10.70

3.00

nmol/l

0.34

725

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

128

1.33

0.47

1.0

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

138

1263

1.09

0.47

2.0

1.7

24.50

4.58

mg/l

6.29

125

964

(3022621) pH of Urine by Test strip

458

4376

1.05

0.46

3.9

2.9

6.12

6.04

1.30

354

3125

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

129

1.32

0.45

1.5

1.1

—

(3034092) Cytoplasmic Ig cells/cells in Blood

1.40

0.45

15.4

11.0

0.60

0.23

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

152

0.72

0.44

1.8

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

109

991

1.10

0.43

1.4

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

284

1.20

0.43

2.3

1.7

38.07

39.45

g/l

0.70

284

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.61

0.43

13.4

9.2

—

(3026726) Creatinine [Moles/volume] in Specimen

1.40

0.42

2.0

2.8

469.50

516.69

umol/l

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.63

0.42

1.2

—

(4212803) Bone marrow aspirate examination

1.38

0.41

1.3

1.1

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.40

0.0

1.1

—

8.25

—

(3020874) Milk IgE Ab [Units/volume] in Serum

159

1.26

0.40

1.0

1.1

0.75

1.61

u/ml

0.67

(3029396) Erythrocyte agglutination [Presence] in Blood

1.43

0.39

2.6

2.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

494

1.13

0.38

1.2

7.10

7.66

mmol/l

0.94

416

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.38

0.38

1.3

1.7

—

(44806420) Estimation of glomerular filtration rate

452

0.86

0.38

2.7

2.5

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

727

0.89

0.38

4.7

4.8

316.57

346.10

umol/l

0.83

627

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

136

0.73

0.37

1.2

1.4

1.18

1.17

mmol/l

—

136

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.35

0.37

1.2

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

116

1.29

0.37

1.0

1.1

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

777

1.10

0.33

1.5

1.3

0.14

0.29

nmol/l

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

237

1.18

0.33

1.6

1.7

11.94

8.47

nmol/l

0.17

202

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

229

1.18

0.32

1.1

1.13

1.19

u/l

0.23

110

(3011985) Renin [Units/volume] in Plasma

770

1.09

0.32

1.3

1.4

43.68

67.39

mu/l

0.90

678

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

427

1.13

0.31

1.1

—

(4094501) Cardiovascular stress test using bicycle ergometer

137

1461

0.94

0.31

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

258

1.16

0.30

1.0

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

138

1.23

0.30

1.0

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.30

0.30

1.9

1.1

1.60

1.77

umol/24h

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.33

0.30

1.0

1.1

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

175

1.20

0.30

1.1

1.3

99.02

134.53

nmol/l

0.77

127

(3027035) Albumin [Mass/time] in 24 hour Urine

1.27

0.30

1.7

1.3

—

640.53

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

132

1241

1.07

0.28

1.6

1.7

—

30.85

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.29

0.28

1.3

2.0

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

333

0.87

0.27

1.0

1.1

5.18

13.64

nmol/l

—

(3011288) Drugs identified in Urine by Screen method Nominal

428

0.89

0.27

9.7

2.5

—

(4146454) Self-monitoring of blood glucose

720

1.08

0.27

2.5

2.8

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

178

1.18

0.26

1.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

225

1.16

0.26

1.2

1.4

—

(1761868) Lipid panel - Serum or Plasma

1542

15631

0.98

0.25

3.7

3.6

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

210

2013

1.04

0.24

1.6

1.8

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

143

1.19

0.23

1.0

1.1

—

(3006462) Nitrate [Presence] in Urine

257

1.13

0.22

5.0

4.0

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

343

1.11

0.22

2.3

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.19

0.21

1.0

1.1

0.03

0.02

u/ml

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.01

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.21

0.0

1.1

—

1316.00

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.4

—

33.35

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.9

—

313.10

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

135

1.19

0.21

1.0

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

156

0.83

0.21

1.0

1.1

—

(3022689) Creatine [Moles/volume] in Urine

177

0.85

0.21

1.5

7.02

7.34

mmol/l

0.14

177

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

0.21

0.0

8.1

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

129

1228

1.05

0.20

1.6

1.9

12.08

9.19

iu/l

0.11

452

(3019225) pH of Specimen

600

5877

1.02

0.20

5.6

4.7

7.37

7.36

1.29

487

4215

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.25

0.20

1.0

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

324

0.89

0.20

1.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.25

0.20

1.2

4.8

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

336

3452

0.97

0.19

1.2

1.3

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

184

1.14

0.19

1.3

1.6

15.22

14.10

g/l

0.21

140

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

251

1.12

0.18

1.0

1.1

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

156

1.15

0.18

1.6

1.4

109.50

446.72

nmol/24h

1.02

156

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

386

1.09

0.18

3.7

5.6

114.15

52.83

u/ml

0.54

121

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

185

1.14

0.18

23.8

19.2

1431.48

1384.58

nmol/l

0.11

179

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.17

0.17

1.0

1.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

113

1080

1.05

0.17

2.1

1.9

194.99

201.58

pmol/l

0.32

101

1008

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.72

0.16

2.8

2.4

0.70

0.63

ug/l

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

492

4828

1.02

0.16

1.4

—

(3002619) Bacteria identified in Specimen by Culture

130

0.85

0.16

1.4

1.2

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

151

0.86

0.15

1.9

2.4

1.24

1.25

ug/l

0.00

143

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

643

1.06

0.15

1.5

1.3

—

nmol/l

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

286

0.91

0.15

1.5

1.4

131.45

194.16

pmol/l

1.03

286

(4211845) Urine protein measurement

284

1.09

0.15

4.8

3.8

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

254

0.91

0.14

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

132

1.14

0.13

1.1

—

(4024509) Urine culture

273

2790

0.98

0.13

2.2

2.0

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

406

0.94

0.12

1.8

122.56

117.46

ng/l

0.11

406

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

268

1.08

0.12

4.1

6.9

9.16

249.96

ug/l

1.19

171

(3014599) Egg white IgE Ab [Units/volume] in Serum

143

1.12

0.11

1.0

1.1

0.60

2.28

u/ml

—

(3014271) Vancomycin [Susceptibility]

357

1.06

0.11

2.9

3.1

—

(3028707) Methadone [Presence] in Urine by Screen method

299

1.07

0.10

2.4

2.2

—

(40762887) Creatinine [Moles/volume] in Blood

1.14

0.10

1.4

1.8

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.14

0.10

1.0

1.2

8.80

11.70

u/l

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1364

13729

0.99

0.09

3.2

3.5

0.72

0.82

ug/l

3.10

986

9805

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.11

0.09

2.2

2.1

14.33

18.65

umol/l

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

339

0.94

0.08

1.3

1.4

27.89

30.72

u/l

0.22

276

(3006442) Creatine [Moles/volume] in Serum or Plasma

338

0.95

0.08

1.9

1.6

80.38

91.36

umol/l

1.85

338

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

176

1.08

0.07

18.5

14.2

807.74

809.52

nmol/l

0.01

167

(3033923) Metanephrine [Moles/time] in 24 hour Urine

108

1.11

0.07

1.3

1.1

0.76

0.70

umol/24h

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

0.86

0.07

1.0

1.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.07

0.07

1.0

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

119

1216

0.98

0.07

6.3

3.8

29.93

30.23

mg/l

0.03

862

(3000034) Microalbumin [Mass/volume] in Urine

529

0.96

0.07

2.4

3.1

60.36

46.03

mg/l

0.21

403

(3027944) Amphetamines [Presence] in Urine

631

1.03

0.06

1.8

1.7

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

208

2103

0.99

0.04

3.0

4.1

62.29

84.28

u/ml

0.65

200

2023

(3002079) Sodium [Moles/time] in 24 hour Urine

209

1.05

0.04

1.4

1.3

138.64

163.68

mmol/24h

0.99

209

(3000764) Benzodiazepines [Presence] in Urine

641

0.98

0.02

1.8

—

(4281824) Cell count and differential, peritoneal fluid

521

1.02

0.02

1.0

1.2

—

(3027008) Opiates [Presence] in Urine

641

1.01

0.01

1.8

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

185

1839

1.01

0.01

1.6

1.7

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

136

0.96

0.00

2.2

7.97

8.15

mmol/l

—

(3006270) Folate [Moles/volume] in Blood

474

1.01

0.00

1.1

1.2

289.92

338.74

nmol/l

0.95

375

(3016879) Cocaine [Presence] in Urine

594

1.01

0.00

1.9

1.8

—

(3028300) Cannabinoids [Presence] in Urine

644

1.01

0.00

1.8

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

502

1.00

0.00

2.0

1.8

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

225

1.02

0.00

1.3

6.05

6.13

mmol/l

0.12

210

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

367

1.01

0.00

1.9

1.4

0.19

0.27

nmol/l

1.10

269

(4133840) Spirometry

109

1.01

0.00

1.3

1.2

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.1

—

1.43

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(4038314) Semen analysis, post vasectomy

0.00

0.0

1.1

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

0.98

-0.00

1.0

1.1

—

(3007463) Buprenorphine [Presence] in Urine

0.00

-0.00

0.0

5.8

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

0.99

-0.00

1.0

1.2

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

25.80

—

(3028717) Thiamine [Mass/volume] in Blood

0.91

-0.00

1.4

1.2

57.57

64.75

ug/l

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

6.2

—

0.30

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

0.93

-0.00

1.2

1.5

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.97

-0.00

1.0

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

1.85

—

(3034614) HLA Ag [Interpretation]

0.00

-0.00

0.0

1.4

—

(3008896) Cortisol [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

304.80

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

3260.00

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: ILD_HOSPITAL_MAIN – ILD, hospital admissions 1, main diag only

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

ILD, hospital admissions 1, main diag only

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for ILD, hospital admissions 1, main diag only (ILD_HOSPITAL_MAIN)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints